Canada Gazette, Part I, Volume 149, Number 9: GOVERNMENT NOTICES
February 28 , 2015
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Notice respecting the Canada-Ontario Agreement on Great Lakes Water Quality and Ecosystem Health
Notice is hereby given that the Minister of the Environment (“the Minister”) has entered into the Canada-Ontario Agreement on Great Lakes Water Quality and Ecosystem Health, 2014 (“the COA”). The Minister is publishing the Agreement in accordance with subsection 9(6) of the Canadian Environmental Protection Act, 1999 (S.C. 1999, c. 33). The Agreement is available on Environment Canada's Web site at www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=969645EE-1.
The governments of Canada and Ontario released a draft COA for public comment on April 24, 2014. The 60-day public comment period ended on July 3, 2014. The Government of Canada published a response document in the Canada Gazette, Part I, on October 4, 2014.
Interested persons requiring additional information about the COA or the Great Lakes should refer to Environment Canada's Web site at www.ec.gc.ca/grandslacs-greatlakes/ or contact Canada.Ontario.Agreement@ec.gc.ca.
February 28, 2015
LEONA AGLUKKAQ
Minister of the Environment
[9-1-o]
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Waiver of information requirements for living organisms (subsection 106(9) of the Canadian Environmental Protection Act, 1999)
Whereas any person who proposes to import or manufacture a living organism that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(1) of the Canadian Environmental Protection Act, 1999;
Whereas any person who proposes to use, manufacture or import for a significant new activity a living organism that is on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(3) of the Canadian Environmental Protection Act, 1999;
Whereas any person who proposes to use for a significant new activity a living organism that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(4) of the Canadian Environmental Protection Act, 1999;
Whereas a person may, pursuant to subsection 106(8) of the Canadian Environmental Protection Act, 1999, request any of the requirements to provide information under subsection 106(1), (3) or (4) of the Canadian Environmental Protection Act, 1999 to be waived; and
Whereas a waiver may be granted by the Minister of the Environment under subsection 106(8) of the Canadian Environmental Protection Act, 1999 if
- (a) in the opinion of the Ministers, the information is not needed in order to determine whether the living organism is toxic or capable of becoming toxic;
- (b) the living organism is to be used for a prescribed purpose or manufactured at a location where, in the opinion of the Ministers, the person requesting the waiver is able to contain the living organism so as to satisfactorily protect the environment and human health; or
- (c) it is not, in the opinion of the Ministers, practicable or feasible to obtain the test data necessary to generate the information;
Therefore, notice is hereby given, pursuant to subsection 106(9) of the Canadian Environmental Protection Act, 1999, that the Minister of the Environment waived the requirement to provide information in accordance with the following annex pursuant to subsection 106(8) of that Act.
KAREN L. DODDS
Assistant Deputy Minister
Science and Technology Branch
On behalf of the Minister of the Environment
ANNEX
Person to whom a waiver is granted | Information concerning a living organism in relation to which a waiver was granted (see note 1) |
---|---|
Agriculture and Agri-Food Canada | Data from tests of antibiotic susceptibility (7) |
OptumInsight Canada Inc. | Data from tests conducted to determine the effects of the micro-organism on aquatic plant, invertebrate and vertebrate species likely to be exposed to it |
Data from tests conducted to determine the effects of the micro-organism on terrestrial plant and invertebrate species likely to be exposed to it |
Note 1 The number in brackets indicates the number of times that the information requirement in the second column was waived for the company between October 1, 2014, and December 31, 2014.
EXPLANATORY NOTE
The decision to grant a waiver is made on a case-by-case basis by Environment Canada in consultation with Health Canada. On average, approximately 100 waivers are granted yearly for chemicals and polymers and organisms for an average of 450 notifications received.
For more information, please see the waivers Web page on the New Substances Web site at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=7F19FF4B-1.
[9-1-o]
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Waiver of information requirements for substances (subsection 81(9) of the Canadian Environmental Protection Act, 1999)
Whereas any person who proposes to import or manufacture a substance that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(1) of the Canadian Environmental Protection Act, 1999;
Whereas any person who proposes to use, manufacture or import for a significant new activity a substance that is on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(3) of the Canadian Environmental Protection Act, 1999;
Whereas any person who proposes to use for a significant new activity a substance that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(4) of the Canadian Environmental Protection Act, 1999;
Whereas a person may, pursuant to subsection 81(8) of the Canadian Environmental Protection Act, 1999, request any of the requirements to provide information under subsection 81(1), (3) or (4) of the Canadian Environmental Protection Act, 1999 to be waived; and
Whereas a waiver may be granted by the Minister of the Environment under subsection 81(8) of the Canadian Environmental Protection Act, 1999 if
- (a) in the opinion of the Ministers, the information is not needed in order to determine whether the substance is toxic or capable of becoming toxic;
- (b) the substance is to be used for a prescribed purpose or manufactured at a location where, in the opinion of the Ministers, the person requesting the waiver is able to contain the substance so as to satisfactorily protect the environment and human health; or
- (c) it is not, in the opinion of the Ministers, practicable or feasible to obtain the test data necessary to generate the information;
Therefore, notice is hereby given, pursuant to subsection 81(9) of the Canadian Environmental Protection Act, 1999, that the Minister of the Environment waived the requirement to provide information in accordance with the following annex pursuant to subsection 81(8) of that Act.
KAREN L. DODDS
Assistant Deputy Minister
Science and Technology Branch
On behalf of the Minister of the Environment
ANNEX
Person to whom a waiver is granted | Information concerning a substance in relation to which a waiver is granted (see note 2) |
---|---|
Allnex Canada Inc. | Data in respect of a number average molecular weight Data in respect of the maximum concentrations, expressed as a percentage, of all residual constituents having molecular weights of less than 500 daltons and of all residual constituents having molecular weights of less than 1 000 daltons |
Archroma Canada Corp. | Data in respect of vapour pressure (3) |
Ashland Canada Corp. | Data in respect of octanol/water partition coefficient Data in respect of hydrolysis rate as a function of pH Data in respect of water extractability Data from an acute aquatic toxicity test |
BASF Canada Inc. | Data in respect of octanol/water partition coefficient Data in respect of vapour pressure Data from a ready biodegradability test |
Brenntag Canada Inc. | Data in respect of octanol/water partition coefficient Data in respect of hydrolysis rate as a function of pH |
Dorf Ketal Chemicals LLC | Data in respect of melting point Data in respect of boiling point Data in respect of density Data in respect of vapour pressure Data in respect of water solubility Data in respect of octanol/water partition coefficient |
Dow Chemical Canada ULC | Data in respect of octanol/water partition coefficient |
E.I. DuPont Canada Inc. | Data in respect of hydrolysis rate as a function of pH Data from a skin sensitization test |
Janssen Inc. | Data in respect of vapour pressure |
Lubrizol Canada Limited | Data in respect of hydrolysis rate as a function of pH Data from an in vivo mutagenicity test |
PPG Canada Inc. | Data in respect of octanol/water partition coefficient |
Quadra Chemicals Ltd. | Data in respect of water extractability Data in respect of octanol/water partition coefficient Data in respect of hydrolysis rate as a function of pH Data from of an acute aquatic toxicity test |
Shell Canada Ltd. | Data in respect of hydrolysis rate as a function of pH (8) |
Synoil Energy Services | Data in respect of vapour pressure (2) |
Tempo Canada Inc. | Data in respect of vapour pressure |
Note 2 The number in brackets indicates the number of times that the information requirement in the second column was waived for the company between October 1, 2014, and December 31, 2014.
EXPLANATORY NOTE
The decision to grant a waiver is made on a case-by-case basis by Environment Canada in consultation with Health Canada. On average, approximately 100 waivers are granted yearly for chemicals and polymers and organisms for an average of 450 notifications received.
For more information, please see the waivers Web page on the New Substances Web site at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=7F19FF4B-1.
[9-1-o]
DEPARTMENT OF THE ENVIRONMENT
SPECIES AT RISK ACT
Description of Ivory Gull critical habitat in the Seymour Island Bird Sanctuary
The Ivory Gull (Pagophila eburnea) is a migratory bird protected under the Migratory Birds Convention Act, 1994 and listed on Schedule 1 of the Species at Risk Act as an endangered species. In Canada, the Ivory Gull is found in Nunavut, the Northwest Territories, and Newfoundland and Labrador. It breeds exclusively in Nunavut. Ivory gulls require breeding sites that are safe from terrestrial predators. The Recovery Strategy for the Ivory Gull (Pagophila eburnea) in Canada, available at www.sararegistry.gc.ca/species/speciesDetails_e.cfm?sid=50, identifies critical habitat for the species in a number of areas, including a federally protected area.
Notice is hereby given that, pursuant to subsection 58(2) of the Species at Risk Act, subsection 58(1) of that Act applies, 90 days after this publication, to the critical habitat of the Ivory Gull, as identified in the recovery strategy for that species on the Species at Risk Public Registry, within the Seymour Island Bird Sanctuary described in the Schedule of the Migratory Bird Sanctuary Regulations made pursuant to the Migratory Birds Convention Act, 1994.
February 2, 2015
MARY TAYLOR
Director
Species at Risk Management
Canadian Wildlife Service
[9-1-o]
DEPARTMENT OF THE ENVIRONMENT
DEPARTMENT OF HEALTH
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Publication after screening assessment of 275 substances specified on the Domestic Substances List (paragraphs 68(b) and (c) or subsection 77(1) of the Canadian Environmental Protection Act, 1999)
Whereas 271 of the 275 substances identified in Annex II below are substances on the Domestic Substances List identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;
Whereas a summary of the draft Screening Assessment conducted on 4 substances pursuant to paragraphs 68(b) and (c) of the Act and on the remaining 271 substances pursuant to section 74 is annexed hereby;
And whereas it is proposed to conclude that these substances do not meet any of the criteria set out in section 64 of the Act,
Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to take no further action on the 4 substances at this time.
And notice therefore is hereby given that the ministers propose to take no further action on the remaining 271 substances at this time under section 77 of the Act.
Public comment period
Any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Government of Canada's Chemical Substances Web site (www.chemicalsubstances.gc.ca). All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Environment Canada, Gatineau, Quebec K1A 0H3, 819-938-3231 (fax), substances@ec.gc.ca (email).
In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.
DAVID MORIN
Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment
AMANDA JANE PREECE
Director General
Safe Environments Directorate
On behalf of the Minister of Health
ANNEX I
Summary of the Draft Screening Assessment
As part of the Chemicals Management Plan, the Government of Canada is assessing and managing, where appropriate, the potential health and ecological risks associated with certain polymers under the Canadian Environmental Protection Act, 1999 (CEPA 1999). These polymers were identified as priorities for further action following the completion of categorization in 2006. A section 71 Notice for Phase 2 of the Domestic Substances List Inventory Update initiative was published in the Canada Gazette, Part I, in December 2012 to collect data on approximately 2 700 substances, including the polymers. As a result of this data collection exercise, 336 polymers were identified as not being in commerce at greater than 1 000 kg during the 2011 calendar year. A polymer rapid screening approach was applied to these 336 polymers that involved using conservative assumptions to identify polymers that warranted further evaluation of their potential to cause harm to either human health or the environment and those that were expected to have a low likelihood of causing harmful ecological or human health effects.
The ecological component of the polymer rapid screening approach consisted of four main steps to identify substances that warranted further evaluation of their potential to cause harm. The first step involved identifying the substances that have similar structural characteristics as polymeric substances that have been previously subject to risk management under the New Substances Notification Regulations (Chemicals and Polymers) [NSNR]. The second and third steps of the process involved identifying polymers that would likely have water extractability less than 2% and determining whether these polymers contained functional groups of concern described in items 1 and 5 of Schedule 7 of the NSNR, respectively. The final step involved applying different exposure scenarios using assumptions that are protective of the environment and drawing a comparison with a conservative acute ecotoxicity value for polymers.
The human health component of the polymer rapid screening approach consisted of a process to determine whether each polymer warranted further assessment from a human health perspective. A key element of the characterization of the potential risk for human health was a determination of the potential for exposure to the general population. Polymers reported to be in commerce in Canada at less than or equal to 1 000 kg during the 2011 calendar year are considered to warrant further assessment if there is evidence of direct exposure (e.g. exposure from products) of the general population in Canada. If the potential for exposure to a polymer is not expected or the polymer is likely to pose a low hazard to human health, it is concluded that the polymer is unlikely to cause harm to human health at current levels of exposure.
Proposed conclusion
In total, 61 polymers were identified as requiring further assessment (5 identified for both ecological and human health considerations, 13 identified for human health considerations only, and 43 identified for ecological considerations only). Based on the information available, it is proposed that the 275 polymers listed in Annex II do not meet any of the criteria under section 64 of CEPA 1999, since they are not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity, that constitute or may constitute a danger to the environment on which life depends, or that constitute or may constitute a danger in Canada to human life or health.
The draft Screening Assessment for these substances is available on the Government of Canada's Chemical Substances Web site (www.chemicalsubstances.gc.ca).
ANNEX II
CAS RN (see note a) or confidential accession number (see note b) | Substance name (see note c) |
---|---|
9003-37-6 | Butanal, polymer with benzenamine |
9003-50-3 | Heptanal, polymer with benzenamine |
9005-12-3 | Poly[oxy(methylphenylsilylene)] |
9008-63-3 | Naphthalenesulfonic acid, sodium salt, polymer with formaldehyde |
9016-83-5 | Formaldehyde, polymer with methylphenol |
9017-72-5 | Naphthalenesulfonic acid, polymer with formaldehyde and 4,4′-sulfonylbis[phenol] |
9022-96-2 | 1-Butanol, titanium(4+) salt, homopolymer |
9060-53-1 | 2,5-Furandione, dihydro-3-(tetrapropenyl)-, polymer with 1-amino-2-propanol and 1,2-ethanediol |
9086-40-2 | Formaldehyde, polymer with (1,1,3,3-tetramethylbutyl)phenol |
12624-35-0 | 9,12-Octadecadienoic acid (Z,Z)-, dimer, polymer with 1,2-ethanediamine |
24937-74-4 | Formaldehyde, polymer with benzenamine and phenol |
24969-10-6 | Oxirane, (chloromethyl)-, polymer with oxirane |
25014-31-7 | Benzene, (1-methylethenyl)-, homopolymer |
25035-68-1 | 2-Propenoic acid, 2-methyl-, polymer with ethenylbenzene and ethyl 2-propenoate |
25035-90-9 | 2-Butenedioic acid (Z)-, dibutyl ester, polymer with ethenyl acetate |
25053-96-7 | Formaldehyde, polymer with 2-methylphenol |
25085-17-0 | 1,2-Ethanediamine, N-(2-aminoethyl)-, polymer with (chloromethyl)oxirane |
25155-81-1 | Formaldehyde, polymer with methylbenzene |
25766-18-1 | Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, homopolymer |
25951-19-3 | 2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with 5-ethenyl-2-methylpyridine and octadecyl 2-methyl-2-propenoate |
26338-45-4 | Aziridine, homopolymer, hydrochloride |
26338-61-4 | 2-Furancarboxaldehyde, polymer with phenol |
26591-12-8 | Guanidine, cyano-, polymer with formaldehyde |
26617-87-8 | Oxirane, methyl-, polymer with oxirane, compd. with iodine |
27553-53-3 | Formaldehyde, polymer with 4-(1,1-dimethylpropyl)phenol |
27754-94-5 | 1,2-Ethanediamine, N,N′-bis(2-aminoethyl)-, polymer with (chloromethyl)oxirane |
28472-87-9 | Guanidine, cyano-, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine |
29086-67-7 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with oxirane |
30584-00-0 | Formaldehyde, polymer with N-(3-aminopropyl)-1,3-propanediamine and 1,3,5-triazine-2,4,6-triamine |
30705-14-7 | Benzenesulfonamide, 2-methyl-, polymer with formaldehyde, 4-methylbenzenesulfonamide and 1,3,5-triazine-2,4,6-triamine |
32311-19-6 | Urea, polymer with formaldehyde and 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane |
32761-96-9 | Benzenediazonium, 2-methoxy-4-(phenylamino)-, salt with 2,4,6-trimethylbenzenesulfonic acid (1:1) polymer with 1,1′-oxybis[4-(methoxymethyl)benzene] |
32844-27-2 | Carbonic dichloride, polymer with 4,4′-(1-methylethylidene)bis[2,6-dibromophenol] and 4,4′-(1-methylethylidene)bis[phenol] |
34323-39-2 | Oxirane, (chloromethyl)-, polymer with ammonium hydroxide ((NH4)(OH)) |
34802-28-3 | Formaldehyde, polymer with benzenamine, methyloxirane, oxirane and phenol |
35297-54-2 | Formaldehyde, polymer with ammonia and phenol |
37189-83-6 | 9,12-Octadecadienoic acid (Z,Z)-, dimer, polymer with N-(2-aminoethyl)-1,2-ethanediamine |
37238-34-9 | Formaldehyde, polymer with nonylphenol and phenol |
37281-91-7 | Lignin, polymer with formaldehyde and phenol |
37337-65-8 | Formaldehyde, polymer with phenol and 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane |
37604-36-7 | Formaldehyde, polymer with phenol and 4-(1,1,3,3-tetramethylbutyl)phenol |
37625-74-4 | Urea, polymer with N-(2-aminoethyl)-1,2-ethanediamine, N,N′-bis(2-aminoethyl)-1,2-ethanediamine and formaldehyde |
37625-93-7 | 2-Propenoic acid, polymer with (chloromethyl)oxirane and 4,4′-(1-methylethylidene)bis[phenol] |
40364-42-9 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane and 4,4′-methylenebis[benzenamine] |
52108-93-7 (see note d) | Lignin, ammonium salt |
53740-05-9 | Dextrin, polymer with formaldehyde |
61472-52-4 | Urea, polymer with N-(2-aminoethyl)-1,2-ethanediamine and formaldehyde |
61827-83-6 | Lignosulfonic acid, copper salt |
62073-57-8 | Urea, N,N′-bis(hydroxymethyl)-, polymer with formaldehyde and (hydroxymethyl)urea |
63494-85-9 | Formaldehyde, polymer with 4-methyl-2-nonylphenol and 4-methylphenol |
63512-71-0 | Formaldehyde, polymer with ammonia and chloroethane |
63784-89-4 | Benzenesulfonic acid, 4-amino-, monosodium salt, polymer with formaldehyde and methylphenol |
63951-50-8 | Naphthalenesulfonic acid, sodium salt, polymer with formaldehyde and 4,4′-sulfonylbis[phenol] |
65733-73-5 | Formaldehyde, polymer with 4,4′-(1-methylethylidene)bis[phenol] and 4-(1,1-dimethylpropyl)phenol |
65733-79-1 | Phenol, polymer with 1-methyl-4-(1-methylethenyl)cyclohexene and 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene |
65733-82-6 | Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol, 4,4′-(1-methylethylidene)bis[phenol] and 4-(1,1,3,3-tetramethylbutyl)phenol |
65997-11-7 | Rosin, fumarated, polymer with pentaerythritol |
67763-03-5 | Silsesquioxanes, Me Ph |
67784-93-4 | Formaldehyde, polymer with 2-methylphenol and phenol, sulfonated, sodium salt |
67784-97-8 | Naphthalenesulfonic acids, polymers with formaldehyde and sulfonated phenol, sodium salts |
67786-28-1 | 2-Naphthalenesulfonic acid, 6-hydroxy-, polymer with formaldehyde, 3-methylphenol and 4-methylphenol, sodium salt |
67816-01-7 | Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with 1,4-cyclohexanedimethanol, 1,3-diisocyanatomethylbenzene, hydrazine and α-hydro-ω-hydroxypoly(oxy-1,4-butanediyl) |
67846-45-1 | 1,3-Propanediamine, N-9-octadecenyl-, (Z)-, polymer with (chloromethyl)oxirane and α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl) |
67905-95-7 | Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and 4-nonylphenol |
67924-33-8 | Ethanol, 2,2′,2″-nitrilotris-, homopolymer, hydrochloride |
67953-56-4 | 1,6-Hexanediamine, N-(6-aminohexyl)-, polymer with (chloromethyl)oxirane |
67953-82-6 | Phenol, 4-dodecyl-, polymer with 1,2-ethanediamine and formaldehyde, compd. with (dibutylamino)methanol |
67970-32-5 | Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and methylphenol |
68003-26-9 | Formaldehyde, polymer with ammonia and 2-methylphenol |
68015-68-9 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 1-[[2-[[2-[bis(2-hydroxyethyl)amino]ethyl](2-hydroxyethyl)amino]ethyl](2-hydroxyethyl)amino]-3-(9-octadecenyloxy)-2-propanol (4:1), (Z)- |
68036-98-6 | Imidazo[4,5-d]imidazole-2,5(1H,3H)-dione, tetrahydro-, polymer with formaldehyde, butylated |
68037-87-6 | Siloxanes and Silicones, Me vinyl |
68072-45-7 | 1,4-Pentadien-3-one, 1,5-bis[4-(oxiranylmethoxy)phenyl]-, polymer with 4,4′-(1-methylethylidene)bis[2,6-dibromophenol] and 4,4′-(1-methylethylidene)bis[phenol] |
68082-23-5 | Cyclosiloxanes, Me vinyl |
68082-91-7 | Rosin, fumarated, polymer with formaldehyde, potassium sodium salt |
68082-95-1 | Rosin, maleated, polymer with bisphenol A, formaldehyde, glycerol and pentaerythritol |
68083-27-2 | Soybean oil, polymer with ethylenediamine, linoleic acid dimer, pentaerythritol, phthalic anhydride and tall oil |
68123-23-9 | Nonanedioic acid, polymer with 1,2-ethanediamine, 1,6-hexanediamine and (Z,Z)-9,12-octadecadienoic acid dimer |
68130-98-3 | Aziridine, homopolymer, ethoxylated, phosphonomethylated |
68134-00-9 | Decanedioic acid, polymer with 1,2-ethanediamine, 1,6-hexanediamine and (Z,Z)-9,12-octadecadienoic acid dimer |
68140-39-6 | Formaldehyde, polymer with (chloromethyl)oxirane, 4,4′-(1-methylethylidene)bis[phenol], methyloxirane, methyloxirane polymer with oxirane ether with 1,2,3-propanetriol (3:1), nonylphenol and oxirane |
68152-47-6 | Rosin, fumarated, polymer with bisphenol A, formaldehyde and pentaerythritol |
68152-60-3 | Rosin, maleated, polymer with bisphenol A, formaldehyde and glycerol |
68152-67-0 | Rosin, maleated, polymer with tripentaerythritol |
68152-68-1 | Rosin, polymer with bisphenol A and formaldehyde |
68154-31-4 | Fatty acids, C14-18, ethoxylated propoxylated |
68155-33-9 | Amines, C14-18-alkyl, ethoxylated |
68155-40-8 | Amines, C16-18 and C18-unsatd. alkyl, ethoxylated |
68188-28-3 | Tall-oil rosin, maleated, polymer with pentaerythritol |
68188-63-6 | Rosin, maleated, polymer with bisphenol A and formaldehyde |
68188-92-1 | Amines, tallow alkyl, propoxylated |
68201-58-1 | Rosin, fumarated, polymer with formaldehyde |
68213-26-3 | Amines, tallow alkyl, ethoxylated propoxylated |
68213-35-4 | Fatty acids, C18-unsatd., dimers, polymers with ethylenediamine, 4-hydroxy-γ-(4-hydroxyphenyl)-γ-methylbenzenebutanoic acid and oleic acid |
68240-07-3 | Phenol, polymer with 6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane and 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene |
68240-08-4 | Phenol, polymer with 3-methylene-6-(1-methylethyl)cyclohexene, 1-methyl-4-(1-methylethenyl)cyclohexene, 1-methyl-4-(1-methylethyl)-1,3-cyclohexadiene, 1-methyl-4-(1-methylethyl)-1,4-cyclohexadiene, 2-methyl-5-(1-methylethyl)-1,3-cyclohexadiene, 1-methyl-4-(1-methylethylidene)cyclohexene and 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene |
68310-21-4 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with α-[[(2-hydroxyethyl)[2-[[2-[(2-hydroxyethyl)octadecylamino]ethyl](2-hydroxy-2-phenylethyl)amino]ethyl]amino]methyl]benzenemethanol (2:1) |
68332-89-8 | Aziridine, homopolymer, propoxylated, benzyl chloride-quaternized |
68333-40-4 | Tung oil, polymer with boron trifluoride-phenol complex, formaldehyde, phenol, β-pinene and turpentine oil |
68333-98-2 (see note e) | Coconut oil, ester with polyethylene glycol mono(nonylphenyl) ether |
68379-09-9 | Benzenesulfonamide, ar-methyl-, polymer with formaldehyde and tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione |
68390-20-5 | Fatty acids, sunflower-oil, polymers with adipic acid, caprolactam, diethylenetriamine and triethylenetetramine |
68400-14-6 | Guanidine, cyano-, polymer with 1,2-ethanediamine sulfate (1:1) and formaldehyde |
68410-22-0 (see note f) | Fatty acids, C18-unsatd., dimers, reaction products with diethylenetriamine |
68412-14-6 | Octadecanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol and urea |
68440-73-3 | Siloxanes and Silicones, di-Me, Me Ph, hydroxy-terminated |
68441-69-0 | 1,2-Ethanediamine, polymer with 1,3-diisocyanatomethylbenzene, reaction products with oleylamine |
68479-80-1 | Phenol, polymer with 1,2-cyclohexanediamine, formaldehyde and 1,6-hexanediamine |
68511-76-2 | 2,5-Furandione, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine, butylated isopropylated, reaction products with triethylamine |
68512-34-5 (see note g) | Lignosulfonic acid, sodium salt, sulfomethylated |
68513-37-1 | Fatty acids, tall-oil, polymers with diethylenetriamine and linoleic acid dimers |
68513-38-2 | Fatty acids, tall-oil, polymers with diethylenetriamine, linoleic acid dimers and triethylenetetramine |
68516-42-7 | 2-Propenoic acid, 2-methyl-, 2-[(1,1-dimethylethyl)amino]ethyl ester, polymer with methyl 2-methyl-2-propenoate and 2-methylpropyl 2-methyl-2-propenoate |
68516-43-8 | 2-Propenoic acid, 2-methyl-, polymer with 2-methylaziridine, methyl 2-methyl-2-propenoate and 2-methylpropyl 2-methyl-2-propenoate |
68516-87-0 | Benzenesulfonic acid, 2,4-dimethyl-, polymer with formaldehyde and 4,4′-sulfonylbis[phenol], ammonium sodium salt |
68527-87-7 | Formaldehyde, polymer with 2-ethoxyethanol and phenol |
68540-48-7 | 9,12-Octadecadienoic acid (Z,Z)-, dimer, compd. with N,N′-bis(2-aminoethyl)-1,2-ethanediamine |
68540-71-6 | Benzoic acid, 2-hydroxy-, polymer with formaldehyde, 2-methylphenol and nonylphenol |
68541-21-9 | 9,12-Octadecadienoic acid (Z,Z)-, polymer with (chloromethyl)oxirane and 4,4′-(1-methylethylidene)bis[phenol] |
68541-77-5 | Decanedioic acid, polymer with 2-aminoethanol, 1,2-ethanediamine and (Z,Z)-9,12-octadecadienoic acid dimer |
68552-99-8 | Fatty acids, vegetable-oil, polymers with phthalic anhydride and rosin |
68553-78-6 | Oils, oiticica, polymers with boron trifluoride-phenol complex, formaldehyde, phenol, β-pinene and turpentine oil |
68554-18-7 | Rosin, fumarated, polymer with glycerol, ammonium salt |
68604-06-8 | Castor oil, hydrogenated, polymer with ethylenediamine, 12-hydroxyoctadecanoic acid and sebacic acid |
68605-92-5 | Fatty acids, tall-oil, reaction products with polyethylenepolyamines, compds. with polyethylene glycol decyl ether phosphate |
68606-78-0 | Naphthenic acids, esters with polytriethanolamine |
68609-24-5 | Formaldehyde, polymer with benzenamine, propoxylated |
68610-07-1 | Formaldehyde, polymers with isobutylenated phenol |
68610-55-9 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane and phenyloxirane, reaction products with 4,4′-methylenebis[benzenamine] |
68610-75-3 | 2-Propenoic acid, 2-methyl-, methyl ester, polymer with 2-mercaptoethanol, reaction products with ammonia and N,N′,2-tris(6-isocyanatohexyl)imidodicarbonic diamide |
68650-48-6 | Fatty acids, C18-unsatd., dimers, polymers with C18-unsatd. alkyl amine dimers and ethylenediamine |
68890-97-1 | Aziridine, homopolymer, compd. with (chloromethyl)benzene |
68891-01-0 | Benzenesulfonamide, ar-methyl-, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine, butylated |
68910-67-8 | Rosin, fumarated maleated, polymer with formaldehyde, potassium sodium salt |
68915-81-1 | Linseed oil, polymer with bisphenol A, bisphenol A diglycidyl ether, diethylenetriamine, formaldehyde, glycidyl Ph ether and pentaethylenehexamine |
68920-24-1 | Fatty acids, dehydrated castor-oil, polymers with bisphenol A, epichlorohydrin, fumaric acid and rosin |
68920-41-2 | Fatty acids, tall-oil, reaction products with polyethylenepolyamines, compds. with polyethylene glycol monooctyl ether phosphate |
68937-31-5 | 4,6,10-Dodecatrien-3-one, 7,11-dimethyl-, cyclized, by-products from, fractionation residues |
68951-99-5 | Siloxanes and Silicones, di-Me, Me vinyl, mono(vinyl group)-terminated |
68952-00-1 | Siloxanes and Silicones, di-Me, mono(vinyl group)-terminated |
68953-74-2 | Aziridine, homopolymer, ethoxylated, phosphonomethylated, sodium salt |
68956-65-0 | Naphthenic acids, polymers with ethylenimine, compds. with linoleic acid dimer |
68988-41-0 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane, reaction products with diethanolamine and polyethylene glycol monooleate |
68988-81-8 | Hexanedioic acid, polymer with bis(2-chloroethyl) (1-hydroxyethyl)phosphonate, 2-chloroethyl hydrogen (2-chloroethyl)phosphonate, 2-chloroethyl hydrogen (1-hydroxyethyl)phosphonate, (E)-2,3-dibromo-2-butene-1,4-diol, 1,3-diisocyanatomethylbenzene and 2,2′-oxybis[ethanol], reaction products with diethanolamine, hydrochlorides |
68988-82-9 | Hexanedioic acid, polymer with bis(2-chloroethyl) (1-hydroxyethyl)phosphonate, 2-chloroethyl hydrogen (2-chloroethyl)phosphonate, 2-chloroethyl hydrogen (1-hydroxyethyl)phosphonate, (E)-2,3-dibromo-2-butene-1,4-diol, 1,3-diisocyanatomethylbenzene and 1,2-propanediol, reaction products with diethanolamine, hydrochlorides |
68989-80-0 | Fatty acids, linseed-oil, polymers with glycerol, maleic anhydride, phthalic anhydride, rosin and tung oil |
69011-21-8 | Benzene, diethenyl-, polymer with ethenylbenzene and ethenylethylbenzene, sulfonated, ammonium salts |
69178-40-1 | Formaldehyde, polymer with benzenamine and 2-ethylbenzenamine |
69898-35-7 | Urea, polymer with formaldehyde and 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane, butylated |
69898-36-8 | Urea, polymer with formaldehyde and 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane, butylated ethylated |
69929-35-7 | Decanedioic acid, polymer with 1,2-ethanediamine, (Z,Z)-9,12-octadecadienoic acid dimer and 4,4′-(1,3-propanediyl)bis[piperidine] |
69929-44-8 | 9,12-Octadecadienoic acid (Z,Z)-, dimer, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine and 1,2-ethanediamine, acetate |
70528-79-9 | Sulfite liquors and Cooking liquors, spent, polymer with formaldehyde |
70693-20-8 | Cyanamide, reaction products with carbon dioxide, ethylene oxide and 1-octadecanamine |
70750-07-1 | Formaldehyde, polymer with N-(2-aminoethyl)-1,2-ethanediamine, benzylated |
70851-21-7 | Siloxanes and Silicones, di-Me, (C3-33-alkyloxy)-terminated |
71042-85-8 | 2-Propenoic acid, 2-methyl-, telomer with 2-[(1,1-dimethylethyl)amino]ethyl 2-methyl-2-propenoate, 1-dodecanethiol, methyl 2-methyl-2-propenoate and exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl 2-methyl-2-propenoate |
71077-22-0 | Benzoic acid, 2-hydroxy-, polymer with formaldehyde, 4-nonylphenol and zinc oxide (ZnO) |
71412-29-8 | 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, telomer with tert-dodecanethiol, ethenylbenzene, isodecyl 2-methyl-2-propenoate and 2-propenoic acid, compd. with 2-(dimethylamino)ethanol |
72121-75-6 | Formaldehyde, polymer with 2,2′-iminobis[ethanol], 4,4′-(1-methylethylidene)bis[phenol], nonylphenol and 1,3,5-triazine-2,4,6-triamine |
72207-55-7 | Benzenamine, ethylenated, distn. residues |
72361-56-9 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine, (butoxymethyl)oxirane and (chloromethyl)oxirane |
72828-15-0 | Benzene, diethenyl-, polymer with ethenylbenzene, sulfonated, ammonium salts |
72968-37-7 | Amines, C12-18-alkyl, ethoxylated |
73049-34-0 | Alcohols, C16-20, ethoxylated propoxylated |
73297-33-3 | Poly(oxy-1,2-ethanediyl), α-[tris[1-(methylphenyl)ethyl]phenyl]-ω-hydroxy- |
75790-74-8 | 1,2,3-Propanetriol, polymer with 1,3-diisocyanatomethylbenzene, hydrazine, methyloxirane and oxirane |
76649-36-0 | Formic acid, compd. with N-(2-aminoethyl)-1,2-ethanediamine polymer with formaldehyde and urea |
76649-37-1 | Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine, ammonia, (chloromethyl)oxirane, formaldehyde and formic acid, formate hydrochloride sulfate |
76649-45-1 | Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine, (chloromethyl)oxirane, formaldehyde and formic acid |
76649-46-2 | Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine, (chloromethyl)oxirane, formaldehyde and formic acid, formate hydrochloride sulfate |
76822-95-2 | Imides, cyclic, from C15-20 α-alkene-maleic anhydride copolymer and (Z)-N-9-octadecenyl-1,3-propanediamine |
79770-99-3 | Fatty acids, C18-unsatd., dimers, distn. lights, reaction products with α,α′-(1-methyl-1,3-propanediyl)bis[ω-hydroxypoly(oxy-1,2-ethanediyl)] |
82640-14-0 | Naphthalenesulfonic acids, polymers with formaldehyde, sulfonated 1,1′-oxybis[methylbenzene] and sulfonylbis[phenol], ammonium sodium salts |
89394-61-6 | Formaldehyde, polymer with N-(2-aminoethyl)-N′-[2-[(2-aminoethyl)amino]ethyl]-1,2-ethanediamine and benzenamine |
95012-79-6 | Tetraglycerol, monododecyl ether |
95649-04-0 | Naphthalenesulfonic acids, polymers with formaldehyde, sulfonated 1,1′-biphenyl and sulfonylbis[phenol], ammonium sodium salts |
95649-08-4 | Formaldehyde, polymers with sulfonated terphenyl and sulfonylbis[phenol], ammonium sodium salts |
96591-18-3 | Fatty acids, tall-oil, reaction products with 2-amino-2-(hydroxymethyl)-1,3-propanediol and formaldehyde, polymers with acrylonitrile, Et acrylate and Me methacrylate |
96591-23-0 | Formaldehyde, polymers with sulfonated 1,1′-biphenyl, sulfonated terphenyl and sulfonylbis[phenol], ammonium sodium salts |
97969-64-7 | Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with 1-aziridineethanol, formaldehyde, 1,6-hexanediol and 1,3,5-triazine-2,4,6-triamine |
98654-27-4 | Fatty acids, dehydrated castor-oil, polymers with dehydrated castor oil, 2-(dimethylamino)ethanol, isononanoic acid, isophthalic acid, linseed oil, maleic anhydride and pentaerythritol |
100588-10-1 | 2-Propenoic acid, polymer with 2,2′-[1,2-ethanediylbis(oxymethylene)]bis[oxirane] and sodium 2-propenoate |
102082-95-1 | 2-Propenoic acid, ammonium salt, polymer with 2-propenamide and 2-propenenitrile |
102561-59-1 | Hexanedioic acid, polymer with N-(2-aminoethyl)-1,3-propanediamine and N,N″-1,2-ethanediylbis[1,3-propanediamine] |
102984-13-4 | 2-Propenoic acid, sodium salt, polymer with 2,2′-[1,2-ethanediylbis(oxymethylene)]bis[oxirane] |
103458-43-1 | 2-Propenoic acid, polymer with 2-(diethylamino)ethyl 2-propenoate and 2-propenamide, sulfate |
104376-66-1 | Formaldehyde, polymers with branched nonylphenol, ethylene oxide and hexamethylenediamine |
106214-62-4 | Fatty acids, soya, polymers with adipic acid, 1,6-hexanediol, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, isophthalic acid and trimethylolpropane, compds. with triethylamine |
106214-63-5 | Fatty acids, soya, polymers with benzoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, isophthalic acid, pentaerythritol and phthalic anhydride, compds. with triethylamine |
108563-09-3 | Amines, tallow alkyl, ethoxylated, 4-dodecylbenzenesulfonates (salts) |
110392-46-6 | Formaldehyde, reaction products with 1,4-benzenediol and m-phenylenediamine, sulfurized |
110720-55-3 | Oxirane, methyl-, polymer with oxirane, ether with [[3-[(2-hydroxymethylethyl)amino]propyl]imino]bis[propanol] (3:1), N-tallow alkyl derivs., sulfates (esters), ammonium salts |
112484-41-0 | Formaldehyde, polymer with 4-(1,1,3,3-tetramethylbutyl)phenol, hydrobromic acid-terminated |
115559-71-2 | Sulfurous acid, monosodium salt, reaction products with m-cresol-formaldehyde-nonylphenol polymer |
115559-72-3 | Sulfurous acid, monosodium salt, reaction products with m-cresol-formaldehyde polymer |
116265-69-1 | Formaldehyde, reaction products with hexamethylenediamine and oxidized ethylene-propene polymer |
117985-54-3 | Benzenesulfonic acid, hydroxy-, monosodium salt, polymer with benzenamine, formaldehyde, 1,3,5-triazine-2,4,6-triamine and urea, bisulfited |
118460-96-1 | Formaldehyde, polymer with methylphenol, nonylphenol and phenol, bisulfited |
118685-17-9 | Benzenesulfonic acid, 4-amino-, polymer with formaldehyde, 2-methylphenol and phenol, bisulfited |
119147-80-7 | Octadecanoic acid, 12-hydroxy-, homopolymer, 2-hydroxy-3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl ester, polymer with methyl 2-methyl-2-propenoate and oxiranylmethyl 2-methyl-2-propenoate, 2-methyl-2-propenoate 4-nitrobenzoate |
121028-89-5 | 2-Propenoic acid, 2-methyl-, telomer with butyl 2-methyl-2-propenoate, 1-dodecanethiol, 2-mercaptoethanol, methyl 2-methyl-2-propenoate and 2-(3-oxazolidinyl)ethyl 2-methyl-2-propenoate |
121053-40-5 | Amines, N-coco alkyltrimethylenedi-, compds. with acrylic acid-N-(butoxymethyl)-2-propenamide-Et acrylate-styrene polymer and 2-(dimethylamino)ethanol |
121053-44-9 | Pentanedioic acid, dimethyl ester, polymer with N-(2-aminoethyl)-1,2-ethanediamine, ammonia and (chloromethyl)oxirane |
121053-47-2 | Propanoic acid, 2-hydroxy-, compd. with (chloromethyl)oxirane polymer with 2-(methylamino)ethanol, 4,4′-(1-methylethylidene)bis[phenol] and α,α′-[(1-methylethylidene)di-4,1- phenylene]bis[ω-hydroxypoly(oxy-1,2-ethanediyl)] |
121372-53-0 | 2-Propenoic acid, 2-methyl-, methyl ester, telomer with butyl 2-propenoate, tert-dodecanethiol, ethenylbenzene, 2-(methylamino)ethanol and oxiranylmethyl 2-methyl-2-propenoate, (±)-2-hydroxypropanoate (salt) (S)-2-hydroxypropanoate (salt) |
121375-94-8 | Urea, polymer with benzenamine, formaldehyde and 1,3,5-triazine-2,4,6-triamine, bisulfited |
121617-09-2 | Alcohols, C16-18, propoxylated |
121617-10-5 | Rosin, polymd., polymer with maleic anhydride, phthalic anhydride, tall oil, tetrahydroabietyl alc. and trimethylolpropane |
122966-99-8 | Phenol, 2,4,6-tris(1-methylpropyl)-, reaction products with 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane], ethoxylated |
123774-67-4 | Formaldehyde, polymer with ammonium hydroxide ((NH4)(OH)), 4-(1,1-dimethylethyl)phenol and phenol |
124578-08-1 | 1,3-Butadiene, 2-chloro-, homopolymer, reaction products with zinc oxide |
125249-27-6 | Formaldehyde, polymer with methanol and nonylphenol |
125302-07-0 | 2-Propenamide, polymer with formaldehyde and morpholine |
125302-08-1 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-iminobis[ethanol], 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane] and 4-nonylphenol |
125328-35-0 | Amides, from hydrogenated tallow and tetraethylenepentamine, polymers with epichlorohydrin and polyethylene glycol, acetates (salts) |
125328-72-5 | 2-Propenoic acid, 2-methyl-, methyl ester, telomer with butyl 2-propenoate, tert-dodecanediol, ethenylbenzene, 2-(methylamino)ethanol, oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol |
125329-08-0 | 9-Octadecenoic acid (Z)-, polymer with copper(2+) sulfate (1:1), 2,5-furandione and oxybis[propanol] |
125351-98-6 | Aziridine, homopolymer, reaction products with epichlorohydrin and polyethylene glycol, acetates |
125352-08-1 | Amines, N-C12-22-alkyltrimethylenedi-, ethoxylated |
125352-10-5 | Sulfuric acid copper(2+) salt (1:1), polymer with 2,5-furandione and oxybis[propanol] |
125378-97-4 | 2-Propenoic acid, butyl ester, polymer with ethenylbenzene, methyl 2-methyl-2-propenoate, oxiranylmethyl 2-methyl-2-propenoate, 1,2-propanediol mono(2-methyl-2-propenoate) and 2,2′-thiobis[ethanol] |
125826-31-5 | 1,2-Benzenedicarboxylic acid, di-2-propenyl ester, polymer with (Z)-butyl hydrogen 2-butenedioate, butyl 2-methyl-2-propenoate, ethenylbenzene, 2-ethylhexyl 2-propenoate, 2-hydroxyethyl 2-methyl-2-propenoate, 12-hydroxyoctadecanoic acid homopolymer 2-hydroxy-3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl ester, methyl 2-methyl-2-propenoate, 2-methyl-2-propenoic acid and oxiranylmethyl 2-methyl-2-propenoate, 4-nitrobenzoate |
125826-39-3 | Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with 1,4-cyclohexanedimethanol, 1,3-diisocyanatomethylbenzene, hydrazine and α-hydro-ω-hydroxypoly(oxy-1,4-butanediyl), compd. with N,N-diethylethanamine |
128801-08-1 | Formaldehyde, polymer with 4,4′-(1-methylethylidene)bis[phenol], 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)bis[oxirane] and phenol |
128971-25-5 | Fatty acids, polymers with isophthalic acid, linoleic acid dimer and triethylenetetramine |
129126-83-6 | Linseed oil, polymer with benzoic acid, formaldehyde, pentaerythritol, phenol, phthalic anhydride, rosin, TDI, 3a,4,7,7a-tetrahydro-1,3-isobenzofurandione and trimethylolpropane |
129126-87-0 | Linseed oil, polymer with benzoic acid, formaldehyde, pentaerythritol, phenol, phthalic anhydride, rosin, TDI, 3a,4,7,7a-tetrahydro-1,3-isobenzofurandione and trimethylolpropane, compds. with 2-(dimethylamino)ethanol |
129420-90-2 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-iminobis[ethanol] and 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane] |
129783-27-3 | Guanidine, cyano-, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine, sulfonated, sodium salts |
129783-43-3 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-iminobis[ethanol] and 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane], reaction products with polyethylene glycol monostearate |
129783-50-2 | Benzenesulfonamide, 4-amino-, polymer with (chloromethyl)oxirane, 4,4′-(1-methylethylidene)bis[2,6-dibromophenol] and 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane] |
129870-85-5 | Hexanedioic acid, polymer with 1,3-isobenzofurandione, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and oxybis[propanol], 2-hydroxyethyl acrylate-blocked |
144030-98-8 | Benzenesulfonic acid, 4-hydroxy-, polymer with formaldehyde and urea, reaction products with aniline, 1,3-bis(hydroxymethyl)urea, 4,5-dihydroxy-1,3-bis(hydroxymethyl)-2-imidazolidinone, disodium disulfite, formaldehyde, tetrahydro-3,5-bis(hydroxymethyl)-1 |
144031-00-5 | Propanoic acid, 2-hydroxy-, compds. with bisphenol A-epichlorohydrin-polyethylene glycol ether with bisphenol A (2:1) polymer-2-(methylamino)ethanol reaction products |
144238-33-5 | 2-Propenoic acid, 2-methyl-, reaction products with bisphenol A-bisphenol A diglycidyl ether polymer benzoate and styrene |
147170-42-1 | 2-Propenoic acid, telomer with 1-dodecanethiol, S-oxides, ammonium salts |
150226-40-7 | Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol, 4,4′-(1-methylethylidene)bis[phenol] and 4-methylphenol, magnesium oxide complex |
150226-41-8 | Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and 4,4′-(1-methylethylidene)bis[phenol], magnesium oxide complex |
154862-02-9 | Rosin, polymd., polymer with maleic anhydride, phthalic anhydride, tall oil, tetrahydroabietyl alc. and trimethylolethane |
155240-18-9 | Benzenesulfonic acid, dodecyl-, reaction products with succinic anhydride monopolyisobutylene derivs., tetraethylenepentamine and zinc oxide |
160611-46-1 | 2,5-Furandione, telomer with ethenylbenzene and (1-methylethyl)benzene, C8-rich C7-9-isoalkyl esters |
165307-61-9 | 1,3-Isobenzofurandione, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol and 1,2,3-propanetriol, benzoate (9Z,12Z)-9,12-octadecadienoate |
176227-30-8 | Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and oxirane, esters with tall-oil fatty acids |
10008-0 (see note h) | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane] and diethanolamine and poly(oxyalkylenediyl), α-(1-oxo-9-octadecenyl)-ω-hydroxy-, (Z)- |
10009-1 (see note i) | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane] and bis(2-substituted ethyl) amine |
10011-3 (see note j) | Cyanoguanidine polymer with diammonium sulfate and an alkyl aldehyde |
10017-0 (see note k) | Amido amine composed of 1,3-propanediamine, N-(3-aminoalkyl)-N-methyl and fatty acids, C18-unsaturated dimers |
10697-5 (see note l) | Metal alkenylsuccinate |
10709-8 (see note m) | Piperazine, 1,2-alkyldiamine, formaldehyde and (chloromethyl)oxirane, polymer |
11048-5 (see note n) | Fatty acids, tall-oil, reaction products with polyethylene glycol, and dicarboxylic acid, salt with reaction products of fatty acids, tall-oil and polyalkylenepolyamine |
11054-2 (see note o) | Nonyl phenol, ethoxylated, monoester with dicarboxylic acid, neutralized with reaction products of tall-oil fatty acids and polyalkylenepolyamine |
11065-4 (see note p) | Fatty acids, tall oil, reaction product with polyalkyenepolyamine and phosphoric acid |
11108-2 (see note q) | Phosphoric acid, polysubstituted amino resin, amino substituted borate |
11111-5 (see note r) | Amino amide composed of 1,4-piperazinedialkylamine and fatty acids, C18-unsatd. dimers |
11114-8 (see note s) | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane] and diethanolamine and poly(oxyalkylenediyl), α.-oxooctadecyl)-ω-hydrox- |
11118-3 (see note t) | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with chloromethyl)oxirane, 1,3,5-triazine-2,4,6-triamine polymer with formaldehyde, and substituted benzoic acid, 1-propanol, 2-(dimethylamino)-2-methyl-, salt |
11126-2 (see note u) | Substituted bis disubstituted heteropolycycle, polymer with (chloromethyl)oxirane, dihydro-2,5-furandione and 4,4′-(1-methylethylidene) bis[phenol], alkanoate, 2-propenoate, metal salt |
11135-2 (see note v) | Tall oil rosin, polymer with alkanoic acid, disubstituted heteropolycyclic acid and 1,3-propanediol, 2-ethyl-2-(hydroxymethyl)- |
11147-5 (see note w) | Polymer of aromatic acids, tall oil fatty acid, polyols, N,N-dimethylethanolamine, methanol, melamine and formaldehyde |
11154-3 (see note x) | Polymer of linseed oil, pentaerythritol, isophthalic acid, monobasic acid, rosin, and maleic anhydride |
11176-7 (see note y) | Fatty acids, C18-unsaturated, dimers, polymers with tall-oil fatty acids and tetraethylenepentamine, reaction products with bisphenol A-epichlorhydrin condensate and polyalkylenepolyamines |
11201-5 (see note z) | Polymer of linseed and chinawood oils and synthetic rosin, pentaerythritol and solid resin |
11431-1 (see note aa) | Poly(allyl methacrylate/butyl acrylate/2-substituted ethyl acrylate/methacrylic acid/methyl methacrylate) 2-amino-2-methyl-1-propanol salt |
11436-6 (see note bb) | Reaction product of alkenylsarcosine, polyoxypropylenediamine and zinc stearate |
11459-2 (see note cc) | Naphtha (petroleum), light steam cracked, debenzenised, polymer with alkylphenol and formaldehyde |
11461-4 (see note dd) | Rosin, maleated, polymer with a carbonyl compound and pentaerythritol, calcium, magnesium and zinc salts |
11470-4 (see note ee) | Rosin, polymer with p-tert-butylphenol, formaldehyde, glycerol and an alkylphenol |
11471-5 (see note ff) | Rosin, polymer with an alkylphenol, bisphenol A, formaldehyde and glycerol |
11472-6 (see note gg) | Rosin, maleated, polymer with a carbonyl compound, calcium, magnesium and zinc salts |
11475-0 (see note hh) | Fatty acids, polymerized, reaction products with diethylenetriamine and tall-oil fatty acids |
11512-1 (see note ii) | Phenol, 4,4′-(methylethylidene)bis-, polymer with (chloromethyl)oxirane, methyloxirane, and combined [oxy(methyl-1,2-ethanediyl)] |
11513-2 (see note jj) | Reaction product of alkylphenol, formaldehyde, monoethanolamine, ethylene oxide and propylene oxide |
11588-5 (see note kk) | Reaction product of: (4,4′-(1-Methylethylidene)bisphenol polymer with substituted methyl(oxirane) and 5-amino-1,3,3 trimethyl cyclohexane methanamine and N,N-bis(aminoethyl)-1,2-ethanediamine |
11589-6 (see note ll) | Reaction product of: 4,4′-(1-Methyethylidene)bisphenol polymer with substituted methyl(oxirane) and 5-amino-1,3,3-trimethyl cyclohexane methanamine and 2,2,4 (or 2,4,4)trimethyl-1,6-hexanediamine |
- Note a The Chemical Abstracts Service Registry Number (CAS RN) is the property of the American Chemical Society, and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society.
- Note b A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note c Masked names are allowed by CEPA 1999 if the publication of the explicit chemical or biological name of a substance would result in the release of confidential business information.
- Note d These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note e These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note f These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note g These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note h A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note i A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note j A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note k A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note l A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note m A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note n A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note o A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note p A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note q A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note r A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note s A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note t A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note u A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note v A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note w A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note x A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note y A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note z A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note aa A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note bb A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note cc A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note dd A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note ee A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note ff A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note gg A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note hh A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note ii A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note jj A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note kk A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
- Note ll A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
[9-1-o]
DEPARTMENT OF THE ENVIRONMENT
DEPARTMENT OF HEALTH
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Publication after screening assessment of 612 substances specified on the Domestic Substances List (paragraphs 68(b) and (c) or subsection 77(1) of the Canadian Environmental Protection Act, 1999)
Whereas the 576 of the 612 substances identified in Annex II below are substances on the Domestic Substances List identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;
Whereas a summary of the draft Screening Assessment conducted under paragraphs 68(b) and (c) of the Act on 36 substances, and under section 74 for the remaining 576 substances, is annexed hereby;
And whereas it is proposed to conclude that the 612 substances do not meet any of the criteria set out in section 64 of the Act,
Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to take no further action on 36 of the substances at this time.
Notice is further given that the ministers propose to take no further action on the remaining 576 substances at this time under section 77 of the Act.
Public comment period
Any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Government of Canada's Chemical Substances Web site (www.chemicalsubstances.gc.ca). All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Environment Canada, Gatineau, Quebec K1A 0H3, 819-938-3231 (fax), substances@ec.gc.ca (email).
In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.
DAVID MORIN
Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment
AMANDA JANE PREECE
Director General
Safe Environments Directorate
On behalf of the Minister of Health
ANNEX I
Summary of the Draft Screening Assessment
As part of the Government of Canada's Chemicals Management Plan, a section 71 notice for the second phase of the Domestic Substances List (DSL) Inventory Update (IU) initiative was published in the Canada Gazette, Part I, on December 1, 2012, to collect data on approximately 2 700 substances. As a result, 869 substances were identified as candidates for rapid screening. The substances included in this report were candidates for rapid screening because they were identified as being in commerce across Canada at a total of 1 000 kg/year or less, according to information submitted pursuant to section 71 of the Canadian Environmental Protection Act, 1999 (CEPA 1999) regarding commercial activity in Canada under Phase 2 of the DSL IU.
The majority of the 869 substances met the categorization criteria for persistence or bioaccumulation and inherent toxicity to human or non-human organisms or for “greatest potential for exposure” to humans under subsection 73(1) of CEPA 1999. Some substances considered in this assessment had been identified as posing a high hazard to human health based on classifications by other national or international agencies for carcinogenicity, genotoxicity, developmental toxicity or reproductive toxicity.
A rapid screening approach was applied that involved using conservative assumptions to identify substances that warrant further evaluation of their potential to cause harm to either human health or the environment, and those that are expected to have a low likelihood of causing harmful ecological or human health effects.
The ecological component consisted of two main steps to identify substances that warrant further evaluation of their potential to cause harm. The first step involved applying different exposure scenarios using assumptions that are protective of the environment. The second step involved a mechanical process to identify whether or not a substance appeared on any of a wide range of lists or in sources of information relating to ecological hazard or exposure. This step flagged substances that have been identified by domestic or international initiatives as possibly being of greater concern due to their ecological hazard properties or elevated potential for environmental release.
The human health component consisted of a process to determine whether the substance warranted further assessment based on the potential for exposure to the general population. Substances reported to be in commerce in Canada at less than or equal to 1 000 kg/year are considered to warrant further assessment only if there is evidence of direct exposure (e.g. exposure from products or processed foods) for the general population in Canada. If the potential for exposure is considered to be negligible for a substance, it is concluded that the substance is unlikely to cause harm to human health at current levels of exposure.
In total, 257 substances were identified as requiring further assessment (40 identified for both ecological and human health considerations, 199 identified for human health considerations only, and 18 identified for ecological considerations only). For the remaining 612 substances, this rapid screening approach indicated that current use patterns and quantities in commerce are unlikely to result in concerns for organisms or the broader integrity of the environment, or for human health in Canada.
Proposed conclusion
It is proposed to conclude that these 612 substances do not meet any of the criteria set out in section 64 of CEPA 1999.
Because these 612 substances are listed on the Domestic Substances List, their import and manufacture in Canada are not subject to notification under the New Substances Notification Regulations of CEPA 1999. Although a risk to the environment or human health has not been identified, 39 substances in this assessment are recognized as having properties of concern. There may be a concern for the environment or for human health if exposures to these substances were to increase. Options on how best to monitor changes in the use profiles of these substances are being investigated and may include application of the Significant New Activity provisions and/or addition to the DSL IU.
The draft Screening Assessment for these substances is available on the Government of Canada's Chemical Substances Web site (www.chemicalsubstances.gc.ca).
ANNEX II
CAS RN (see note 3) | Domestic Substances List name |
---|---|
50-41-9 | Ethanamine, 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) |
50-50-0 | Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-benzoate |
50-52-2 | 10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)- |
50-53-3 | 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl- |
51-28-5 | Phenol, 2,4-dinitro- |
51-48-9 | L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo- |
52-86-8 | 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1- (4-fluorophenyl)- |
57-12-5 | Cyanide |
60-87-7 | 10H-Phenothiazine-10-ethanamine, N,N,α-trimethyl- |
60-99-1 | 10H-Phenothiazine-10-propanamine, 2-methoxy-N,N,β-trimethyl-, (βR)- |
70-30-4 | Phenol, 2,2′-methylenebis[3,4,6-trichloro- |
72-33-3 | 19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy-, (17α)- |
72-69-5 | 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl- |
79-54-9 | 1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,9,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, [1R-(1α,4aβ,4bα,10aα)]- |
80-10-4 | Silane, dichlorodiphenyl- |
83-66-9 | Benzene, 1-(1,1-dimethylethyl)-2-methoxy-4-methyl-3,5-dinitro- |
84-96-8 | 10H-Phenothiazine-10-propanamine, N,N,β-trimethyl- |
85-00-7 | Dipyrido[1,2-a:2′,1′-c]pyrazinediium, 6,7-dihydro-, dibromide |
88-58-4 | 1,4-Benzenediol, 2,5-bis(1,1-dimethylethyl)- |
89-47-4 | Butanoic acid, 3-methyl-, 5-methyl-2-(1-methylethyl)cyclohexyl ester, (1α,2β,5α)- |
91-50-9 | Benzoic acid, 2-[[2-methyl-3-[4-(1-methylethyl)phenyl]propylidene]amino]-, methyl ester |
95-19-2 | 1H-Imidazole-1-ethanol, 2-heptadecyl-4,5-dihydro- |
95-73-8 (see note 1a) | Benzene, 2,4-dichloro-1-methyl- |
97-23-4 | Phenol, 2,2′-methylenebis[4-chloro- |
98-95-3 | Benzene, nitro- |
99-82-1 | Cyclohexane, 1-methyl-4-(1-methylethyl)- |
100-46-9 (see note 1b) | Benzenemethanamine |
100-99-2 | Aluminum, tris(2-methylpropyl)- |
101-65-5 | Carbamic acid, (methylenedi-4,1-phenylene)bis-, diphenyl ester |
105-58-8 (see note 1c) | Carbonic acid, diethyl ester |
109-72-8 | Lithium, butyl- |
111-83-1 | Octane, 1-bromo- |
112-29-8 | Decane, 1-bromo- |
112-52-7 | Dodecane, 1-chloro- |
115-71-9 | 2-Penten-1-ol, 5-(2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl)-2-methyl-, stereoisomer |
118-65-0 | Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1R-(1R,4Z,9S)]- |
120-83-2 | Phenol, 2,4-dichloro- |
121-21-1 | Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, 2-methyl-4-oxo-3-(2,4-pentadienyl)-2-cyclopenten-1-yl ester, [1R-[1α[S(Z)],3β]]- |
123-69-3 | Oxacycloheptadec-8-en-2-one, (Z)- |
128-66-5 | Dibenzo[b,def]chrysene-7,14-dione |
129-09-9 | Anthra[2,1-d:6,5-d′]bisthiazole-6,12-dione, 2,8-diphenyl- |
129-73-7 | Benzenamine, 4,4′-(phenylmethylene)bis[N,N-dimethyl- |
133-66-4 (see note 1d) | Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4,6-bis(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt |
135-88-6 (see note 1e) | 2-Naphthalenamine, N-phenyl- |
140-29-4 (see note 1f) | Benzeneacetonitrile |
140-41-0 (see note 1g) | Acetic acid, trichloro-, compd. with N′-(4-chlorophenyl)-N,N-dimethylurea (1:1) |
140-73-8 | 1,6-Hexanediamine, N,N′-bis(3-phenyl-2-propenylidene)- |
141-38-8 (see note 1h) | Oxiraneoctanoic acid, 3-octyl-, 2-ethylhexyl ester |
149-11-1 | Hexanoic acid, 2-ethyl-, copper(2+) salt |
151-50-8 | Potassium cyanide (K(CN)) |
297-76-7 | 19-Norpregn-4-en-20-yne-3,17-diol, diacetate, (3β,17α)- |
302-79-4 | Retinoic acid |
357-57-3 | Strychnidin-10-one, 2,3-dimethoxy- |
360-70-3 | Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17β)- |
420-04-2 | Cyanamide |
485-19-8 | 7-Isoquinolinol, 1,2,3,4-tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-, (1S)- |
506-64-9 | Silver cyanide (Ag(CN)) |
506-68-3 | Cyanogen bromide ((CN)Br) |
514-10-3 | 1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, [1R-(1α,4aβ,4bα,10aα)]- |
519-73-3 | Benzene, 1,1′,1″-methylidynetris- |
522-00-9 | 10H-Phenothiazine-10-ethanamine, N,N-diethyl-α-methyl- |
537-00-8 | Acetic acid, cerium(3+) salt |
537-01-9 | Carbonic acid, cerium(3+) salt (3:2) |
541-09-3 | Uranium, bis(acetato-O)dioxo- |
542-76-7 | Propanenitrile, 3-chloro- |
542-83-6 | Cadmium cyanide (Cd(CN)2) |
544-19-4 | Formic acid, copper(2+) salt |
544-92-3 | Copper cyanide (Cu(CN)) |
556-61-6 | Methane, isothiocyanato- |
560-88-3 | Benzoic acid, 2-hydroxy-, 1,7,7-trimethylbicyclo[2.2.1]hept-2-yl ester, endo- |
563-63-3 | Acetic acid, silver(1+) salt |
587-26-8 | Carbonic acid, lanthanum(3+) salt (3:2) |
590-28-3 | Cyanic acid, potassium salt |
592-01-8 | Calcium cyanide (Ca(CN)2) |
592-82-5 | Butane, 1-isothiocyanato- |
592-85-8 | Thiocyanic acid, mercury(2+) salt |
605-01-6 | Benzene, pentaethyl- |
622-20-8 | Benzene, 1,1′-[1,2-ethanediylbis(thio)]bis- |
739-71-9 | 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,β-trimethyl- |
751-94-0 | 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, monosodium salt, (3α,4α,8α,9β,11α,13α, 14β,16β,17Z)- |
814-91-5 | Ethanedioic acid, copper(2+) salt (1:1) |
917-70-4 | Acetic acid, lanthanum(3+) salt |
950-33-4 | Cyclododecane, 1,1-dimethoxy- |
969-33-5 | Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-, hydrochloride |
979-32-8 | Estra-1,3,5(10)-triene-3,17-diol (17β)-, 17-pentanoate |
1025-15-6 | 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tri-2-propenyl- |
1096-48-6 | 9,10-Anthracenedione, 1-(cyclohexylamino)- |
1120-44-1 | 9-Octadecenoic acid (Z)-, copper(2+) salt |
1135-66-6 | 2H-2,4a-Methanonaphthalene, 1,3,4,5,6,7-hexahydro-1,1,5,5-tetramethyl-, (2S)- |
1172-18-5 | 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride |
1209-61-6 | 5-Oxatricyclo[8.2.0.04,6]dodecane, 4,9,12,12-tetramethyl- |
1299-86-1 | Aluminum carbide (Al4C3) |
1313-97-9 | Neodymium oxide (Nd2O3) |
1314-20-1 | Thorium oxide (ThO2) |
1314-61-0 | Tantalum oxide (Ta2O5) |
1324-58-9 | Diindolo[3,2-b:3′,2′-m]triphenodioxazinetrisulfonic acid, 8,18-dichloro-5,15-diethyl-5,15-dihydro-, trisodium salt |
1329-99-3 | Cyclohexane, 1-methyl-4-(1-methylethyl)-, tetradehydro deriv. |
1331-61-9 | Benzenesulfonic acid, dodecyl-, ammonium salt |
1332-14-5 | Sulfuric acid, copper(2+) salt, basic |
1332-65-6 | Copper chloride hydroxide (Cu2Cl(OH)3) |
1344-67-8 | Copper chloride |
1405-92-1 | 1H-3a,7-Methanoazulene-6-methanol, 2,3,4,7,8,8a-hexahydro-3,8,8-trimethyl-, acetate, [3R-(3α,3aβ,7β,8aα)]- |
1446-61-3 | 1-Phenanthrenemethanamine, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, [1R-(1α,4aβ,10aα)]- |
1470-61-7 | Silver, (diethylcarbamodithioato-S,S′)- |
1478-61-1 | Phenol, 4,4′-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis- |
1622-61-3 | 1-Pyrrolidinepropanol, α-cyclohexyl-α-phenyl-, hydrochloride |
1746-23-2 | Benzene, 1-(1,1-dimethylethyl)-4-ethenyl- |
1796-92-5 | Benzoic acid, 5-[(3-carboxy-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)(2,6-dichlorophenyl)methyl]-2-hydroxy-3-methyl-, disodium salt |
1799-84-4 | 2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,6-nonafluorohexyl ester |
1817-68-1 | Phenol, 4-methyl-2,6-bis(1-phenylethyl)- |
1922-67-4 | 1H-Naphtho[2,3-c]pyran, 3,4,6,7,8,9-hexahydro-4,6,6,9,9-pentamethyl- |
2026-24-6 | 1-Phenanthrenemethanamine, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, acetate, [1R-(1α,4aβ,10aα)]- |
2144-53-8 | 2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester |
2162-73-4 | Benzene, 2,4-diisocyanate-1,3,5-tris(1-methylethyl)- |
2386-52-9 | Methanesulfonic acid, silver(1+) salt |
2451-84-5 | Hexanedioic acid, bis(phenylmethyl) ester |
2611-00-9 | 3-Cyclohexene-1-carboxylic acid, 3-cyclohexen-1-ylmethyl ester |
2944-30-1 | 9,10-Anthracenedione, 1,4-bis[(4-methoxyphenyl)amino]- |
2966-50-9 | Acetic acid, trifluoro-, silver(1+) salt |
3042-75-9 | Benzeneacetic acid, α-chloro-α-phenyl-, 2-(dimethylamino)ethyl ester, hydrochloride |
3089-55-2 | Hexanedioic acid, octyl phenylmethyl ester |
3251-84-1 | Methanaminium, N-[4-[[4-(cyclohexylamino)-1-naphthalenyl][4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, chloride |
3253-39-2 | 2-Propenoic acid, 2-methyl-, (1-methylethylidene)di-4,1-phenylene ester |
3315-16-0 | Cyanic acid, silver(1+) salt |
3333-62-8 | 2H-1-Benzopyran-2-one, 7-(2H-naphtho[1,2-d]triazol-2-yl)-3-phenyl- |
3444-14-2 | Carbonic acid, copper(1+) salt |
3526-75-8 | 5-Azulenemethanol, decahydro-α,α,3,8-tetramethyl-, [3S-(3α,3aβ,5α,8α,8aβ)]- |
3564-75-8 | 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,β-trimethyl-, (-)- |
3572-52-9 (see note 1i) | 1,1′-Biphenyl -3-carboxylic acid, 2-hydroxy-, 2-(diethylamino)ethyl ester |
3688-79-7 | 7H-Benz[de]anthracen-7-one, 3-methoxy- |
3860-63-7 | 9,10-Anthracenedione, 1,5-dihydroxy-4,8-bis(methylamino)- |
3910-35-8 | 1H-Indene, 2,3-dihydro-1,1,3-trimethyl-3-phenyl- |
4091-99-0 | Benzoic acid, 2-[3,6-bis(acetyloxy)-2,7-dichloro-9H-xanthen-9-yl]- |
4105-12-8 | Cyclohexanol, 3-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)-, [1α,2α(1S,3S),4α,6α]- |
4111-54-0 | 2-Propanamine, N-(1-methylethyl)-, lithium salt |
4196-86-5 | 1,3-Propanediol, 2,2-bis[(benzoyloxy)methyl]-, dibenzoate |
4203-77-4 | [3,3′-Bianthra[1,9-cd]pyrazole]-6,6′(1H,1′H)-dione, 1,1′-diethyl- |
4216-01-7 | 7H-Benzo[e]perimidine-4-carboxamide, N-(9,10-dihydro-9,10-dioxo-1-anthracenyl)-7-oxo- |
4270-70-6 | Sulfonium, triphenyl-, chloride |
4330-99-8 | 10H-Phenothiazine-10-propanamine, N,N,β-trimethyl-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) |
4424-87-7 | Benzo[1,2-c:4,5-c′]diacridine-6,9,15,18(5H,14H)-tetrone |
4499-91-6 | Docosanoic acid, lithium salt |
4702-65-2 | 9,10-Anthracenedione, 4,8-diamino-1,5-dihydroxy-2-(4-hydroxy-3-methylphenyl)- |
4759-48-2 | Retinoic acid, 13-cis- |
4802-20-4 | Cyclohexaneethanethiol, 3-mercapto-β,4-dimethyl- |
5284-79-7 | Cyclohexanone, 2,6-bis[(4-azidophenyl)methylene]-4-methyl- |
5875-45-6 | Phenol, 2,5-bis(1,1-dimethylethyl)- |
6028-47-3 | 2-Pentanol, 4-methyl-, hydrogen phosphorodithioate |
6070-16-2 | Hexanoic acid, 5-methyl-2-(1-methylethyl)cyclohexyl ester, (1α,2β,5α)- |
6130-43-4 | Heptanoic acid, tridecafluoro-, ammonium salt |
6144-04-3 | Benzene, (1-methylethenyl)-, dimer |
6196-94-7 | Benzene, 1-ethyl-4-(1-phenylethyl)- |
6196-95-8 | Benzene, 1,2-dimethyl-4-(1-phenylethyl)- |
6221-92-7 | Cyclododecanol, acetate |
6252-76-2 | Xanthylium, 9-(2-carboxyphenyl)-3-[(2-methylphenyl)amino]-6-[(2-methyl-4-sulfophenyl)amino]-, hydroxide, inner salt, monosodium salt |
6291-95-8 | 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(2-methyl-2-propenyl)- |
6408-57-7 | Benzenesulfonic acid, 2,2′-[(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino]bis[5-butyl-, disodium salt |
6661-40-1 | Benzenesulfonic acid, 2-ethoxy-5-[[4-[[4-[(4-ethoxy-3-sulfophenyl)amino]phenyl](1-methyl-2-phenyl-1H-indol-3-yl)methylene]-2,5-cyclohexadien-1-ylidene]amino]-, monosodium salt |
6804-07-5 (see note 1j) | Hydrazinecarboxylic acid, [(1,4-dioxido-2-quinoxalinyl)methylene]-, methyl ester |
6990-06-3 | 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3α,4α,8α,9β,11α,13α,14β,16β,17Z)- |
7098-08-0 | 9,10-Anthracenedione, 4,8-diamino-1,5-dihydroxy-2-(4-hydroxyphenyl)- |
7158-25-0 | 4,9:5,8-Dimethano-1H-benz[f]indene, 3a,4,4a,5,8,8a,9,9a-octahydro- |
7360-44-3 | Aluminum, (acetato-O)dihydroxy- |
7435-02-1 | Octanoic acid, cerium salt |
7439-15-8 | Benzene, 1-ethyl-4-(2-phenylethyl)- |
7439-91-0 | Lanthanum |
7439-94-3 | Lutetium |
7440-45-1 | Cerium |
7440-65-5 | Yttrium |
7488-49-5 | 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2R,6R,11R)- |
7647-10-1 | Palladium chloride (PdCl2) |
7717-62-6 | Benzeneacetic acid, 1-phenyl-1,2-ethanediyl ester |
7758-88-5 | Cerium fluoride (CeF3) |
7774-29-0 | Mercury iodide (HgI2) |
7782-39-0 | Deuterium |
7783-33-7 | Mercurate(2-), tetraiodo-, dipotassium, (T-4)- |
7783-49-5 | Zinc fluoride (ZnF2) |
7783-70-2 | Antimony fluoride (SbF5) |
7783-86-0 | Iron iodide (FeI2) |
7783-96-2 | Silver iodide (AgI) |
7784-09-0 | Phosphoric acid, trisilver(1+) salt |
7789-45-9 | Copper bromide (CuBr2) |
7790-80-9 | Cadmium iodide (CdI2) |
7790-86-5 | Cerium chloride (CeCl3) |
7790-98-9 | Perchloric acid, ammonium salt |
7803-58-9 | Sulfamide |
7803-63-6 | Sulfuric acid, monoammonium salt |
8023-64-1 (see note 1k) | Balsams, Peru, white |
8038-93-5 | Sodium aluminum chlorhydroxy lactate |
9008-34-8 | Resin acids and Rosin acids, manganese salts |
10024-42-7 | Aluminum sodium sulfate |
10024-93-8 | Neodymium chloride (NdCl3) |
10025-67-9 | Sulfur chloride (S2Cl2) |
10025-74-8 | Dysprosium chloride (DyCl3) |
10028-17-8 | Tritium |
10042-88-3 | Terbium chloride (TbCl3) |
10045-89-3 | Sulfuric acid, ammonium iron(2+) salt (2:2:1) |
10049-07-7 | Rhodium chloride (RhCl3) |
10049-23-7 | Telluric acid (H2TeO3) |
10099-59-9 | Nitric acid, lanthanum(3+) salt |
10102-05-3 | Nitric acid, palladium(2+) salt |
10108-73-3 | Nitric acid, cerium(3+) salt |
10138-04-2 | Sulfuric acid, ammonium iron(3+) salt (2:1:1) |
10138-41-7 | Erbium chloride (ErCl3) |
10138-52-0 | Gadolinium chloride (GdCl3) |
10168-81-7 | Nitric acid, gadolinium(3+) salt |
10361-65-6 | Phosphoric acid, triammonium salt |
10361-79-2 | Praseodymium chloride (PrCl3) |
10361-82-7 | Samarium chloride (SmCl3) |
10361-92-9 | Yttrium chloride (YCl3) |
10361-93-0 | Nitric acid, yttrium(3+) salt |
10402-16-1 | 9-Octadecenoic acid (Z)-, copper salt |
10402-33-2 | Benzeneacetic acid, 2-methoxy-4-(2-propenyl)phenyl ester |
10484-56-7 | Naphthalene, 2-butoxy- |
10579-93-8 | Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1S-(1R,4E,9S)]- |
10580-02-6 | Titanate(2-), bis[ethanedioato(2-)-O,O′]oxo-, diammonium, (SP-5-21)- |
11028-42-5 | Cedrene |
12003-63-3 | Aluminate (AlO21-), potassium |
12004-40-9 | Aluminate (AlO33-), strontium (2:3) |
12013-15-9 | Copper hydroxide sulfate (Cu3(OH)4(SO4)) |
12014-14-1 | Cadmium titanium oxide (CdTiO3) |
12027-06-4 | Ammonium iodide ((NH4)I) |
12027-67-7 | Molybdate (Mo7O246-), hexaammonium |
12030-97-6 | Titanate (TiO32-), dipotassium |
12034-34-3 | Titanate (TiO32-), disodium |
12049-50-2 | Titanate (TiO32-), calcium (1:1) |
12057-24-8 | Lithium oxide (Li2O) |
12061-16-4 | Erbium oxide (Er2O3) |
12075-68-2 | Aluminum, trichlorotriethyldi- |
12124-99-1 | Ammonium sulfide ((NH4)(SH)) |
12135-77-2 | Ammonium sulfide ((NH4)2(S5)) |
12138-09-9 | Tungsten sulfide (WS2) |
12192-57-3 | Gold, [1-(thio-.kappa.S)-D-glucopyranosato-.kappa.O2 |
12196-21-3 | Hemimorphite (Zn4(OH)2O(SiO3)2.H2O) |
12227-77-9 | Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, chloride, aluminum salt |
12254-24-9 | Aluminate (Al12O192-), strontium (1:1) |
12307-90-3 | Rhodium, chloro[(1,2,5,6-η)-1,3,5,7-cyclooctatetraene](pyridine)- |
12542-85-7 | Aluminum, trichlorotrimethyldi- |
12593-60-1 | Ammonium phosphate sulfate ((NH4)2H3(PO4)(SO4)) |
12794-95-5 (see note 1l) | Silicic acid, ammonium salt |
13005-35-1 | D-Gluconic acid, copper salt |
13011-54-6 | Phosphoric acid, monoammonium monosodium salt |
13019-04-0 | Cyclohexanone, 2,4-bis(1,1-dimethylethyl)- |
13106-76-8 | Molybdate (MoO42-), diammonium, (T-4)- |
13393-93-6 | 1-Phenanthrenemethanol, tetradecahydro-1,4a-dimethyl-7-(1-methylethyl)- |
13444-93-4 | Osmium chloride (OsCl3) |
13446-48-5 | Nitrous acid, ammonium salt |
13453-07-1 | Gold chloride (AuCl3) |
13453-87-7 | Sulfurous acid, dilithium salt |
13454-72-3 | Metaphosphoric acid (HPO3), cerium(3+) salt |
13465-98-0 | Sulfurous acid, disilver(1+) salt |
13573-16-5 | Chromate(1-), diamminetetrakis(thiocyanato-N)-, ammonium, (OC-6-11)- |
13596-12-8 | Aluminum fluoride oxide (AlFO) |
13598-65-7 | Rhenate (ReO41-), ammonium, (T-4)- |
13693-11-3 | Sulfuric acid, titanium(4+) salt (2:1) |
13709-38-1 | Lanthanum fluoride (LaF3) |
13709-49-4 | Yttrium fluoride (YF3) |
13786-79-3 | 13-Oxabicyclo[10.1.0]trideca-4,8-diene, 1,5,9-trimethyl- |
13820-53-6 | Palladate(2-), tetrachloro-, disodium, (SP-4-1)- |
13821-15-3 | Aluminate(1-), tetrafluoro-, sodium, (T-4)- |
13823-29-5 | Nitric acid, thorium(4+) salt |
14049-51-5 | Aluminum, hydroxybis(octanoato-O)- |
14220-17-8 | Nickelate(2-), tetrakis(cyano-C)-, dipotassium, (SP-4-1)- |
14263-73-1 | Cuprate(3-), tetrakis(cyano-C)-, tripotassium, (T-4)- |
14284-93-6 | Ruthenium, tris(2,4-pentanedionato-O,O′)-, (OC-6-11)- |
14307-35-8 | Chromic acid (H2CrO4), dilithium salt |
14475-17-3 | Carbonic acid, praseodymium salt |
14816-18-3 | 3,5-Dioxa-6-aza-4-phosphaoct-6-ene-8-nitrile, 4-ethoxy-7-phenyl-, 4-sulfide |
15007-61-1 | Aluminum potassium sulfate |
15114-15-5 | 9,10-Anthracenedione, 4,8-diamino-2-(4-ethoxyphenyl)-1,5-dihydroxy- |
15281-91-1 | Cuprate(3-), tetrakis(cyano-C)-, trisodium, (T-4)- |
15336-18-2 | Rhodate(3-), hexachloro-, triammonium, (OC-6-11)- |
15467-06-8 | 9-Octadecenoic acid, 12-hydroxy-, monolithium salt, [R-(Z)]- |
15680-42-9 | Copper, [1-[[(2-hydroxyphenyl)imino]methyl]-2-naphthalenolato(2-)-N,O,O′]- |
15710-63-1 | Aluminum ammonium sulfate |
15752-05-3 | Iridate(3-), hexachloro-, triammonium, (OC-6-11)- |
16774-21-3 | Cerate(2-), hexakis(nitrato-O)-, diammonium, (OC-6-11)- |
16871-54-8 | Platinate(2-), hexachloro-, (OC-6-11)- |
16903-35-8 | Aurate(1-), tetrachloro-, hydrogen, (SP-4-1)- |
16919-19-0 | Silicate(2-), hexafluoro-, diammonium |
16919-31-6 | Zirconate(2-), hexafluoro-, diammonium, (OC-6-11)- |
16919-58-7 | Platinate(2-), hexachloro-, diammonium, (OC-6-11)- |
16921-30-5 | Platinate(2-), hexachloro-, dipotassium, (OC-6-11)- |
16923-58-3 | Platinate(2-), hexachloro-, disodium, (OC-6-11)- |
16940-92-4 | Iridate(2-), hexachloro-, diammonium, (OC-6-11)- |
16941-12-1 | Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)- |
17202-41-4 | 1-Nonanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-nonadecafluoro-, ammonium salt |
17439-11-1 | Titanate(2-), hexafluoro-, dihydrogen, (OC-6-11)- |
17527-29-6 | 2-Propenoic acid, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester |
17831-71-9 | 2-Propenoic acid, oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ester |
17836-88-3 | Aluminate(1-), diethyldihydro-, sodium, (T-4)- |
18263-25-7 | Hexadecanoic acid, 2-bromo- |
18400-34-5 | Bismuth carbonate |
18908-70-8 | Benzene, 1-ethyl-2-(1-phenylethyl)- |
18908-71-9 | Benzene, 1-ethyl-3-(1-phenylethyl)- |
19014-53-0 | 9,10-Anthracenedione, 1-amino-2-[4-[(hexahydro-2-oxo-1H-azepin-1-yl)methyl]phenoxy]-4-hydroxy- |
19125-99-6 | 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-butyl-6-(butylamino)- |
19398-61-9 (see note 1m) | Benzene, 1,4-dichloro-2-methyl- |
19941-28-7 | 1-Phenanthrenecarboxylic acid, tetradecahydro-1,4a-dimethyl-7-(1-methylethyl)-, methyl ester, [1R-(1α,4aß,4bα ,7ß,8aß,10aα)]- |
21064-19-7 | 1,5,9-Cyclododecatriene, 1,5,9-trimethyl- |
21656-02-0 | Rhodium hydroxide (Rh(OH)3) |
22722-98-1 | Aluminate(1-), dihydrobis(2-methoxyethanolato-O,O′)-, sodium |
23149-52-2 | Thiosulfuric acid (H2S2O3), disilver(1+) salt |
24304-00-5 | Aluminum nitride (AlN) |
24447-78-7 | 2-Propenoic acid, (1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyl)ester |
24484-01-3 | Copper, chloro[tris(2-chloroethyl) phosphite-P]- |
24593-34-8 | Hexanoic acid, 2-ethyl-, cerium salt |
24772-51-8 | Aluminum, bis(2-butanolato)(ethyl 3-oxobutanoato-O1′,O3)-, (T-4)- |
25155-18-4 | Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[methyl-4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride |
25339-17-7 | Isodecanol |
25567-55-9 | Phenol, tetrachloro-, sodium salt |
25614-03-3 | Ergotaman-3′,6′,18-trione, 2-bromo-12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-, (5′α)- |
26401-27-4 | Phosphorous acid, isooctyl diphenyl ester |
26545-58-4 (see note 1n) | Naphthalenesulfonic acid, methylenebis-, disodium salt |
26603-40-7 (see note 1o) | 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(3-isocyanatomethylphenyl)- |
26628-22-8 | Sodium azide (Na(N3)) |
26747-90-0 | 1,3-Diazetidine-2,4-dione, 1,3-bis(3-isocyanatomethylphenyl)- |
27080-90-6 | Disulfide, bis(dimethylphenyl) |
27157-94-4 | Phosphorodithioic acid, O,O-bis(methylphenyl) ester |
27441-86-7 | Imidodisulfuric acid, ammonium salt |
28984-89-6 | 1,1′-Biphenyl, phenoxy- |
29935-35-1 | Arsenate(1-), hexafluoro-, lithium |
31113-23-2 | Aurate(1-), tetrachloro-, ammonium, (SP-4-1)- |
31288-44-5 | 9,10-Anthracenedione, 1,5-diamino-4,8-dihydroxy(4-methoxyphenyl)- |
31529-83-6 | 9,10-Anthracenedione, 1,5-diamino-4,8-dihydroxy(4-hydroxyphenyl)- |
31884-77-2 (see note 1p) | Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-, hydrochloride, hydrate (1:2:1) |
32222-06-3 | 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1α,3β,5Z,7E)- |
32510-27-3 | 2(3H)-Benzothiazolethione, copper salt |
33703-04-7 | Acetic acid, 2,2′,2″-[(1,1,3-tributyl-1-distannathianyl-3-ylidene)tris(thio)]tris-, triisooctyl ester |
33704-59-5 | 1H-Indene, 2,3,4,5,6,7-hexahydro-1,1,2,3,3-pentamethyl- |
33704-60-8 | 1H-Indene, octahydro-1,1,2,3,3-pentamethyl- |
34455-03-3 | 1-Hexanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-(2-hydroxyethyl)- |
35164-39-7 | Propanoic acid, 2-methyl-, ester with 2,2,4-trimethyl-1,3-pentanediol monobenzoate |
35171-52-9 | Arsenic triiodide |
38303-23-0 | Cyclododecoxazole, 4,5,6,7,8,9,10,11,12,13-decahydro- |
38462-23-6 | Pyridine, 4-(4,8-dimethyl-3,7-nonadienyl)- |
38970-76-2 | Benzoic acid, 2-hydroxy-, dilithium salt |
40785-62-4 | Cyclododeca[c]furan, 1,3,3a,4,5,6,7,8,9,10,11,13a-dodecahydro- |
41284-31-5 | 1,4-Benzenedicarboxylic acid, 2-[[4-(2,2-dicyanoethenyl)-3-methylphenyl]ethylamino]ethyl methyl ester |
42757-85-7 | 1H-Benz[f]indene-1,3(2H)-dione, 2-(3-hydroxy-2-quinolinyl)- |
47107-74-4 | Copper, iodo(triphenylphosphine)- |
47742-71-2 | Xanthylium, 3,6-bis(diethylamino)-9-[2-(methoxycarbonyl)phenyl]- |
50288-23-8 | Arsenic triiodide |
50471-44-8 | 2,4-Oxazolidinedione, 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl- |
50542-90-0 | 2H-1-Benzopyran-2-one, 7-[(3,7-dimethyl-2,6-octadienyl)oxy]-4-methyl- |
52236-80-3 | Acetic acid, [4-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)oxy]phenoxy]-, ethyl ester |
52475-89-5 | 3-Cyclohexene-1-carboxaldehyde, 3-(4-methyl-3-pentenyl)- |
52591-27-2 | 2-Propenoic acid, 3,3,4,4,5,5,6,6,6-nonafluorohexyl ester |
53004-93-6 | Butanoic acid, 2-methyl-, 5-methyl-2-(1-methylethyl)cyclohexyl ester |
53422-16-5 | Octadecanoic acid, 12-hydroxy-, methyl ester, lithium salt |
54464-54-9 | Ethanone, 1-[1,6-dimethyl-3-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]- |
55200-89-0 | Copper hydroxide sulfate |
56208-99-2 | Aluminum, bis(2-ethylhexanoato-O)(2-propanolato)- |
56211-60-0 | Potassium titanium fluoride |
57499-57-7 | Ethanone, 1-[1,6-dimethyl-4-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]- |
58102-02-6 | 3-Butenal, 2-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)- |
58394-64-2 | Hexanedioic acid, 2-ethylhexyl phenylmethyl ester |
58478-76-5 | Octadecanoic acid, 12-hydroxy-, calcium lithium salt |
60270-55-5 | 1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, potassium salt |
60304-36-1 | Aluminum potassium fluoride |
60364-28-5 | Pentanoic acid, 2-propyl-, bismuth salt |
61617-09-2 | 9H-Dibenzo[b,d]pyran-9-one, 3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl -, (6aR,10aR)- |
61788-56-5 | Naphthenic acids, lithium salts |
61788-80-5 | Resin acids and Rosin acids, iron salts |
61788-83-8 (see note 1q) | Oils, herring, sulfated, sodium salts |
61789-75-1 | Quaternary ammonium compounds, benzyldimethyltallow alkyl, chlorides |
61790-11-2 | Fatty acids, tall-oil, zinc salts |
61790-20-3 | Naphthenic acids, rare earth salts |
61790-54-3 | Naphthenic acids, compds. with N-tallow alkyltrimethylenediamines |
62563-80-8 | Vetiverol, acetate |
62625-30-3 | Phenol, 4,4′-(3H-2,1-benzoxathiol-3-ylidene)bis[2-bromo-6-methyl-, S,S-dioxide, monosodium salt |
62638-04-4 | Cyclohexanebutanoic acid, silver(1+) salt |
63148-76-5 | Benzoxazolium, 3-ethyl-5-phenyl-2-[2-[[3-(3-sulfopropyl)-2(3H)-benzoxazolylidene]methyl]-1-butenyl]-, hydroxide, inner salt |
63568-35-4 | Naphthalenedisulfonic acid, diisononyl-, compd. with 1,1′-iminobis[2-propanol] (1:2) |
64129-94-8 | Pentanoic acid, 5-methyl-2-(1-methylethyl)cyclohexyl ester, [1R-(1α,2β,5α)]- |
64754-89-8 (see note 1r) | Naphthenic acids (petroleum), crude |
64755-02-8 | Fatty acids, tallow, lithium salts |
65816-20-8 | Benzoic acid, 4-[[(ethylphenylamino)methylene]amino]-, ethyl ester |
66071-82-7 | Fatty acids, tallow, hydrogenated, lithium salts |
67567-23-1 | Butanoic acid, 3,3-bis[(1,1-dimethylpropyl)dioxy]-, ethyl ester |
67584-53-6 | Glycine, N-ethyl-N-[(tridecafluorohexyl)sulfonyl]-, potassium salt |
67584-58-1 | 1-Propanaminium, N,N,N-trimethyl-3-[[(pentadecafluoroheptyl)sulfonyl]amino]-, iodide |
67584-62-7 | Glycine, N-ethyl-N-[(pentadecafluoroheptyl)sulfonyl]-, potassium salt |
67634-12-2 | Benzoic acid, 2-[[[4-(4-hydroxy-4-methylpentyl)-3-cyclohexenyl]methylene]amino]-, methyl ester |
67801-30-3 | 4-Penten-3-one, 5-(2,4,6-trimethyl-3-cyclohexen-1-yl)- |
67801-31-4 | 3-Buten-2-one, 3-methyl-4-(3,5,6-trimethyl-3-cyclohexen-1-yl)- |
67801-32-5 | 4-Penten-3-one, 5-(3,5,6-trimethyl-3-cyclohexen-1-yl)- |
67801-36-9 | 1H-Indole-1-heptanol, η-1H-indol-1-yl-α,α,ε-trimethyl |
67801-37-0 | 1H-Indole, 1,1′-(2-phenylethylidene)bis- |
67801-47-2 | Benzoic acid, 2-[(3,7-dimethyl-2,6-octadienylidene)amino]-, methyl ester |
67845-42-5 | Benzoic acid, 2-[(3,7-dimethyl-6-octenylidene)amino]-, methyl ester |
67893-02-1 | 1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-1,4a-dimethyl-7-(1-methylethyl)-, methyl ester |
67905-40-2 | Oxiranecarboxylic acid, 3-methyl-3-[2-(2,6,6-trimethyl-2-cyclohexen-1-yl)ethenyl]-, methyl ester |
67924-13-4 | Benzoic acid, 2-[[2-(phenylmethylene)octylidene]amino]-, methyl ester |
67939-98-4 | 1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-[2-(phosphonooxy)ethyl]-, diammonium salt |
67940-02-7 | 1-Heptanesulfonamide, N-[3-(dimethylamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, monohydrochloride |
68039-12-3 | 1H-Imidazolium, 1-ethyl-4,5-dihydro-3-(2-hydroxyethyl)-2-(8-heptadecenyl)-, ethyl sulfate |
68083-40-9 | Methanone, [2-hydroxy-4-[2-hydroxy-3-(octyloxy)propoxy]phenyl]phenyl- |
68092-49-9 | Methanone, [4-[3-(decyloxy)-2-hydroxypropoxy]-2-hydroxyphenyl]phenyl- |
68131-32-8 (see note 1s) | Sulfite liquors and Cooking liquors, spent, fermented |
68139-87-7 | Fatty acids, tall-oil, compds. with diethylenetriamine-naphthenic acid reaction products |
68155-64-6 | 1-Propanone, 1-[6-methyl-3-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]- |
68155-65-7 | 1-Propanone, 1-[6-methyl-4-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]- |
68186-32-3 | 1,2,4-Benzenetricarboxylic acid, isooctyl ester |
68186-99-2 | C.I. Pigment Red 231 |
68187-06-4 | Naphthalenesulfonic acid, di-C5-6-alkyl derivs., compds. with butylamine |
68187-41-7 | Phosphorodithioic acid, O,O-di-C1-14-alkyl esters |
68187-59-7 (see note 1t) | Coal, anthracite, calcined |
68201-19-4 | Barium, acetate tallow fatty acids complexes |
68228-09-1 | Benzoic acid, 2-[[[2,4(or 3,5)-dimethyl-3-cyclohexen-1-yl]methyl]amino]-, ethyl ester |
68259-07-4 | 1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, ammonium salt |
68259-14-3 | 1-Heptanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-methyl- |
68259-15-4 | 1-Hexanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-methyl- |
68298-13-5 | 1-Pentanesulfonamide, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-methyl- |
68307-87-9 (see note 1u) | Calcium, acetate hydrogenated tallow fatty acids complexes |
68308-19-0 | Fatty acids, C6-19-branched, copper(2+) salts |
68309-34-2 | Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-nortall-oil alkyl, chlorides |
68333-32-4 | Phenol, mixed di-Me and mono-Me derivs., isobutenylated, distn. residues |
68334-11-2 | Fatty acids, tall oil, compds. with 2-[(2-hydroxyphenyl)methylene]hydrazinecarboximidamide |
68400-01-1 | Formic acid, compd. with 2-[2-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulfonyl]ethoxy]-N,N-dimethyl-1-propanamine (1:1) |
68412-02-2 | 2,5-Furandione, dihydro-, mono-C11-13-alkenyl derivs. |
68412-83-9 | Sulfuric acid, mono-C8-30-alkyl esters, compds. with triethanolamine |
68442-12-6 | 9-Octadecenoic acid (Z)-, 2-mercaptoethyl ester, reaction products with dichlorodimethylstannane, sodium sulfide(Na2S) and trichloromethylstannane |
68478-78-4 | 9-Octadecenoic acid (Z)-, reaction products with 2-amino-2-methyl-1-propanol |
68478-92-2 | Platinum, 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complexes |
68514-63-6 | Naphthenic acids, cerium(4+) salts |
68515-67-3 | Copper, 2-ethylhexanoate naphthenate 3,5,5-trimethylhexanoate complexes |
68515-89-9 | Barium, carbonate nonylphenol complexes |
68515-93-5 | Phenol, nonyl derivs., sulfides |
68527-78-6 | Benzoic acid, 2-[[2-(phenylmethylene)heptylidene]amino]-, methyl ester |
68527-79-7 | 7-Octen-2-ol, 8-(1H-indol-1-yl)-2,6-dimethyl |
68551-38-2 | Balsams, copaiba, sulfurized, silver salts |
68551-39-3 | Balsams, Douglas-fir, mixed with turpentine oil, titanium salts |
68555-62-4 | 2-Butenal, 2-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)- |
68555-72-6 | 1-Pentanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-(2-hydroxyethyl)- |
68555-73-7 | 1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-(2-hydroxyethyl)- |
68555-75-9 | 1-Hexanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-(2-hydroxyethyl)-N-methyl- |
68555-76-0 | 1-Heptanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-(2-hydroxyethyl)-N-methyl- |
68555-81-7 | 1-Propanaminium, N,N,N-trimethyl-3-[[(pentadecafluoroheptyl)sulfonyl]amino]-, chloride |
68585-32-0 | Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane |
68603-64-5 | Amines, N-(hydrogenated tallow alkyl)trimethylenedi- |
68608-33-3 | Terpenes and Terpenoids, cedarwood-oil, hydroxy, acetates |
68609-03-0 | Copper, C6-19-branched carboxylate naphthenate complexes |
68610-24-2 (see note 1v) | C.I. Pigment Yellow 157 |
68611-23-4 | 3-Pentanone, 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, reaction products with 2-propyn-1-ol |
68647-36-9 | Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, tungstatesilicate |
68647-67-6 | Sesquiterpenes and Sesquiterpenoids, guaiac wood-oil |
68648-44-2 | Pyrethrins and Pyrethroids, manufg.-residues |
68683-18-1 | Neodecanoic acid, silver(1+) salt |
68738-99-8 | Benzoic acid, 2-[[[2,4(or 3,5)-dimethyl-3-cyclohexen-1-yl]methylene]amino]-, methyl ester |
68784-83-8 | Yttrium oxide sulfide (Y2O2S), europium-doped |
68845-33-0 | Cyclohexane, 1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethyl)-, didehydro deriv. |
68859-25-6 | C.I. Pigment Yellow 37 |
68901-22-4 | Cyclohexanone, 4-[(3,3-dimethylbicyclo[2.2.1]hept-2-yl)methyl]-2-methyl- |
68908-88-3 | Benzene, ethyl-, benzylated |
68909-13-7 | Bastnaesite, calcined conc. |
68916-14-3 (see note 1w) | Oils, amyris, acetylated |
68916-31-4 | Balsams, Douglas-fir, sulfurized, ruthenium salts |
68916-32-5 | Balsams, mixed copaiba and Douglas-fir, sulfurized, silver salts |
68918-07-0 | Sulfonic acids, petrolatum, sodium salts |
68920-10-5 (see note 1x) | Fats, animal, mixed with vegetable oils, deodorizer distillates |
68922-09-8 | Cyclohexanol, 2-methoxy-4-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)- |
68928-29-0 | 1-Octadecanaminium, N,N-diethyl-N-methyl-, (OC-6-11)-hexakis(cyano-C)ferrate(4-) (4:1) |
68938-42-1 | Paraffin waxes and Hydrocarbon waxes, chloro, reaction products with naphthalene |
68952-33-0 | Tar acids, cresylic, C8-rich, phosphates |
68952-90-9 | 1-Propanaminium, N,N-bis(2-aminoethyl)-2-hydroxy-N-methyl-, N,N′-ditallow acyl derivs., Me sulfates (salts) |
68954-59-6 | 9-Octadecenoic acid (Z)-, reaction products with 2-[(2-aminoethyl)amino]ethanol, compds. with di-Et sulfate |
68955-54-4 | Amines, C16-22-tert-alkyl |
68956-12-7 (see note 1y) | Fatty acids, C18-unsatd., dimers, distn. lights |
68957-60-8 | 1-Pentanesulfonamide, N-[3-(dimethylamino)propyl]-1,1,2,2,3,3,4,4,5,5,5-undecafluoro-, monohydrochloride |
68957-61-9 | 1-Hexanesulfonamide, N-[3-(dimethylamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, monohydrochloride |
68957-62-0 | 1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro- |
68990-00-1 | Resin acids and Rosin acids, decarboxylated, potassium salts |
68990-27-2 | Balsams, copaiba, sulfurized, mixed with turpentine, gold salts |
68990-92-1 | Tallow, reaction products with 2-[(2-aminoethyl)amino]ethanol, compds. with di-Et sulfate |
69011-12-7 | 1,2-Benzenedicarboxylic acid, 3,4,5,6-tetrachloro-, butyl ester |
69012-57-3 | Flue dust, cadmium-refining |
69012-60-8 | Flue dust, lead-tin alloy-manufg. |
69012-63-1 | Flue dust, zinc-refining |
69012-86-8 | Ashes (residues), zinc-refining |
69029-45-4 | Lead, dross, antimony-rich |
69029-51-2 | Lead, antimonial, dross |
69029-60-3 | Zinc, desilverizing skims |
69029-61-4 | Bismuth, refinery lead chloride residues |
69029-63-6 | Calcines, cadmium residue |
69029-74-9 | Calcines, lead ore conc. |
69029-79-4 | Residues, lead smelting |
69029-83-0 | Residues, zinc smelting |
69029-91-0 | Slimes and Sludges, cadmium sump tank |
70024-67-8 | Benzenesulfonic acid, C16-24-alkyl derivs. |
70225-15-9 | 1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1) |
70225-16-0 | 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1) |
70892-62-5 | 1-Naphthalenepropanol, α-ethenyldecahydro-2-hydroxy-α,2,5,5,8a-pentamethyl-, [1R-[1α(R),2β,4aβ,8aα]]-, oxidized |
70914-18-0 | Tallow, hydrogenated, reaction products with 2-[(2-aminoethyl)amino]ethanol, compds. with di-Et sulfates |
71205-27-1 | 9,10-Anthracenedione, 1,8-diamino-4,5-dihydroxy-, brominated |
71487-01-9 | Quaternary ammonium compounds, dicoco alkyldimethyl, nitrites |
71827-03-7 | Avermectin A1a, 5-O-demethyl-22,23-dihydro- |
71889-01-5 (see note 1z) | Silane, chlorotrimethyl-, hydrolysis products with silica |
72230-85-4 | Terpenes and Terpenoids, copaiba-oil, hydroxy, acetates |
72403-67-9 | 3-Cyclohexene-1-methanol, 3(or 4)-(4-methyl-3-pentenyl)-, acetate |
72749-59-8 | Quaternary ammonium compounds, tri-C6-12-alkylmethyl, chlorides |
72927-96-9 | 2-Anthracenesulfonic acid, 1-amino-9,10-dihydro-9,10-dioxo-4-[(2,4,6-trimethylphenyl)amino]-, monolithium salt |
73018-55-0 | Platinum, dicarbonyldichloro-, reaction products with 2,4,6-triethenyl-2,4,6-trimethylcyclotrisiloxane |
73049-75-9 (see note 1aa) | Quaternary ammonium compounds, benzyldi-C12-18-alkylmethyl, chlorides |
73240-13-8 | Benzoic acid, 2-hydroxy-, 1-methyl-1,3-propanediyl ester |
73309-46-3 | Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-[(4-ethoxyphenyl)amino]-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, chloride |
73570-52-2 | Phenoxazin-5-ium, 3,7-bis(diethylamino)-, nitrate |
75701-31-4 | Xanthylium, 9-(2,5-dicarboxyphenyl)-3,6-bis(diethylamino)-, hydroxide, inner salt |
79665-42-2 | Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, copper(1+) (OC-6-11)-hexakis(cyano-C)ferrate(4-) (2:2:1) |
79864-11-2 | Benzenamine, N,N′-methanetetraylbis[4-[(4-isocyanatophenyl)methyl]- |
80301-64-0 | 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)- |
82537-67-5 | 1,3,8-Triazaspiro[4.5]decane-2,4-dione, 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl- |
83950-19-0 | Benzenamine, 4-[(2-chlorophenyl)[4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-2-methyl-, sulfate (2:1) |
83968-92-7 | Ethanaminium, N-[4-[(2-chlorophenyl)(1-methyl-2-phenyl-1H-indol-3-yl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, acetate |
84434-47-9 | Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(methylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, acetate |
84776-83-0 (see note 1bb) | Resin acids and Rosin acids, esters with trimethylolpropane |
85005-73-8 | Phenoxazin-5-ium, 3-(ethylamino)-2-methyl-7-[(2-methylphenyl)amino]-, chloride |
85187-74-2 | Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-(methylamino)-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, sodium salt |
85338-07-4 | Aluminum, chloro hydroxy sulfo-1,2-benzenedicarboxylate complexes |
85585-93-9 | Carbonic acid, aluminum magnesium salt, basic |
85586-48-7 | Urea, N,N″-(methylenedi-4,1-phenylene)bis[N′-[3-(triethoxysilyl)propyl]- |
85736-59-0 | Naphthenic acids, bismuth salts |
87396-22-3 (see note 1cc) | Phosphonic acid, [[(phosphonomethyl)imino]bis[6,1-hexanediylnitrilobis(methylene)]]tetrakis-, reaction products with ammonia-diethylene glycol reaction product morpholine derivs. residues |
90066-13-0 | Xanthylium, 9-(2,4-dicarboxyphenyl)-3,6-bis(diethylamino)-, hydroxide, inner salt |
90623-14-6 | Amides, from C18-24 fatty acids, N,N-dimethyl-1,3-propanediamine and hydrogenated tallow fatty acids, compds. with di-Me sulfate |
90989-74-5 (see note 1dd) | Blood, meal |
91053-53-1 | Limestone, reaction product with bauxite and gypsum |
91744-55-7 (see note 1ee) | Glycerides, lard mono-, hydrogenated |
93334-05-5 | Fatty acids, montan-wax, sodium salts |
93892-03-6 | Butanoic acid, 2-methyl-5-(1-methylethenyl)cyclohexyl ester, (1α,2β,5α)- |
93892-05-8 | Butanoic acid, 3-methyl-, 2-methyl-5-(1-methylethenyl)cyclohexyl ester, (1α,2β,5α)- |
93919-04-1 | Butanoic acid, 2-methyl-5-(1-methylethenyl)-2-cyclohexen-1-yl ester |
93940-59-1 | Octanoic acid, 5-methyl-2-(1-methylethyl)cyclohexyl ester, (1α,2β,5α)- |
94094-93-6 (see note 1ff) | Benzene, mono-C10-C13-alkyl derivs., fractionation bottoms, heavy ends |
94248-34-7 | Benzoic acid, 2-[[(trimethyl-3-cyclohexen-1-yl)methylene]amino]-, methyl ester |
94279-42-2 | Ferrate(4-), hexakis(cyano-C)-, oxidized N,N-dimethylbenzenamine-N-ethyl-2-methylbenzenamine-formaldehyde reaction products copper(1+) salts |
94386-39-7 | Butanoic acid, 3-methyl-, 2-methyl-5-(1-methylethenyl)-2-cyclohexen-1-yl ester |
94386-40-0 | Butanoic acid, 3-methyl-, [4-(1-methylethenyl)-1-cyclohexen-1-yl]methyl ester |
97375-25-2 | Platinum, carbonyl chloro 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane complexes |
97862-60-7 | Fatty acids, C20-28, compds. with 2-(methylamino)ethanol |
100085-57-2 | Oils, fish, hydrogenated, reaction products with N,N-dimethyl-1,3-propanediamine, di-Me sulfate-quaternized |
103443-41-0 | Xanthylium, 3,6-bis(diethylamino)-9-[2-(methoxycarbonyl)phenyl]-, molybdatetungstatephosphate |
104037-85-6 | Benzoic acid, 2-[[3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl]amino]-, methyl ester |
106068-87-5 | Benzothiazolium, 5-chloro-2-[[5-[(5-chloro-1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-ylidene)ethylidene]-3-ethyl-4-oxo-2-thiazolidinylidene]methyl]-3-ethyl-, iodide |
106276-79-3 | Benzoic acid, 2,3,4,5-tetrachloro-6-cyano-, methyl ester, reaction products with 2-methyl-1,3-benzenediamine and sodium methoxide |
106726-11-8 | Neodecanoic acid, neodynium(3+) salt |
107630-41-1 | Nitric acid, ammonium calcium salt (11:1:5) |
107667-02-7 | Phophinodithioic acid, bis(2,4,4-trimethylpentyl)- |
109037-75-4 | Benzene, reaction products with chlorine and sulfur chloride (S2Cl2), hexafluoroantimonates(1-) |
114488-10-7 | 10H-Phenothiazine, 10-[2-[(2S)-1-methyl-2-piperidinyl]ethyl]-2-(methylthio)- |
114862-93-0 | Methylium, [4-(dimethylamino)phenyl]bis[4-(ethylamino)-3-methylphenyl]-, molybdatephosphate |
114887-05-7 | Methylium, bis[4-(dimethylamino)phenyl][4-(ethylamino)-3-methylphenyl]-, molybdatephosphate |
115017-00-0 | 10H-Phenothiazine-10-ethanamine, N,N-diethyl-a-methyl-, (-)- |
117920-00-0 | Amines, C16-22-tert-alkyl, compds. with 2(3H)-benzothiazolethione (1:1) |
119040-04-9 | Cyclohexanol, 2-methyl(trimethylbicyclo[2.2.1]hept-2-yl)- |
119299-02-4 | Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, hydroxides |
121028-72-6 | Aluminum, hydroxybis(1-oxodecyl)- |
121028-73-7 | Aluminum, dihydroxy(1-oxooctyl)- |
121053-36-9 | Slimes and Sludges, nickel refining |
121053-43-8 | Aluminum, dihydroxy(1-oxodecyl)- |
121754-48-1 | Benzenediazonium, 2-methoxy-4-(phenylamino)-, salt with 3,5-dimethylbenzenemethanesulfonic acid (1:1), reaction products with 1-(methoxymethyl)-4-(4-methylphenoxy)benzene and 1,1′-oxybis[4-(methoxymethyl)benzene] |
121754-49-2 | 2,4-Pentanedione, reaction products with 2-methyl-2-propanol, nonylphenol and tungsten chloride (WCl6) |
123774-64-1 | Aluminum, (2-ethylhexanoato-O)dihydroxy- |
125328-39-4 | Amines, N-canola-oil alkyltrimethylenedi- |
125328-45-2 | Amines, hydrogenated tallow alkyl, distn., residues |
125328-62-3 | Nitriles, canola-oil |
125328-63-4 | Nitriles, canola-oil, hydrogenated |
125328-86-1 | 2-Anthracenesulfonic acid, 1-amino-4-[[4-(1,1-dimethylethyl)phenyl]amino]-9,10-dihydro-9,10-dioxo-, monolithium salt |
125328-87-2 | Benzene, 1-ethyl-2-(2-phenylethyl)- |
125328-94-1 | Benzene, 1-ethyl-3-(2-phenylethyl)- |
125494-53-3 | Slags, aluminum refining |
125494-54-4 | Slimes and Sludges, zinc refining |
126820-94-8 | Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1+) salt, reaction products with palladium isooctyl 3-mercaptopropanoate complexes, sulfur and 2,6,6-trimethylbicyclo[3.1.1]heptanethiol silver(1+) salt |
126820-96-0 | Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1+) salt, reaction products with sulfur and 2,6,6-trimethylbicyclo[3.1.1]heptanethiol silver(1+) salt |
127032-53-5 (see note 1gg) | Protein hydrolyzates, poultry-feather |
129618-38-8 | Solutions, nickel hydrometallurgical |
132373-76-3 | 2-Naphthalenesulfonic acid, 1,5-bis(1-methylethyl)-, compd. with cyclohexanamine (1:1) |
134098-61-6 | Benzoic acid, 4-[[[(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino]oxy]methyl]-, 1,1-dimethylethyl ester |
143106-84-7 | 2-Butanone, 4-[[[1,2,3,4,4a,9,10,10a- octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenyl ]methyl](3-oxo-3-phenylpropyl)amino]-, hydrochloride, [1R-(1α,4aα)]- |
152923-48-3 (see note 1hh) | Amylase, α-, Bacillus amyloliquefaciens |
- Note 3 The Chemical Abstracts Service Registry Number (CAS RN) is the property of the American Chemical Society, and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society.
- Note 1a These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1b These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1c These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1d These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1e These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1f These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1g These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1h These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1i These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1j These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1k These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1l These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1m These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1n These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1o These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1p These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1q These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1r These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1s These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1t These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1u These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1v These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1w These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1x These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1y These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1z These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1aa These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1bb These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1cc These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1dd These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1ee These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1ff These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1gg These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
- Note 1hh These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
Confidential accession number (see note 4) | Masked name |
---|---|
10003-4 | Sulfurized alkyl phenols |
10004-5 | Maleic acid reaction product with alkyl amine |
10034-8 | Alkylsalicylic acid, zinc salt |
10035-0 | Alkylsalicylic acid, zinc salt |
10688-5 | Alkylsalicylic acid, sodium salt |
10701-0 | Adipic acid, product with C16C18 alcohols and alkenylsuccinic anhydride |
11005-7 | Dialkyl(alkyldimethylsiloxy)aluminum |
11035-1 | Diethanolamine salts of mono- and bis(1H,1H,2H,2H-perfluoroalkyl)phosphates |
11043-0 | Diethylene triamine distearamide diglycidyl ether |
11099-2 | 2,4-Alkyldione metal salt |
11140-7 | Substituted phosphinodithioate, zinc salt |
11163-3 | N,N′,N″-(Tris-(2-hydroxyethyl)-N-(alkyl-1,3-diaminopropane)), molybdate |
11166-6 | Soybean oil product with sulfur and alkene and organic acid |
11192-5 | Bisalkoxylated aluminum acetoacetic ester chelate |
11193-6 | Fatty acids, C18-unsaturated, dimers, distillation, lights, esters with a monohydric alcohol |
11194-7 | Bis alkoxylated aluminum acetoacetic ester chelate |
11199-3 | Modified tri-oxyaluminum alkanoate |
11204-8 | Ethoxylated alkyl alcohol phosphate salts of alkyl octahydrophenanthridine |
11444-5 | Substituted aromatic diisocyanate - hydroxypropyl methacrylate resin |
11500-7 | 1-Methyl, N-methoxycarbonyl, N′-[2-(perfluoroalkyl)ethoxy]carbonyl-2,4-diaminobenzene |
11517-6 | Monodithiocarbamate of amines, N-(3-aminopropyl)-N-alkyl-, trimethylenedi- |
11519-8 | Reaction product of dicyclopentadiene, naphtha, (petroleum), steam cracked middle aromatics, maleic anhydride and terpene |
11522-2 | Fatty acids, reaction products with maleic anhydride and oleylamine |
11523-3 | Fatty acids, reaction products with maleic anhydride and oleylamine, ethoxylated |
11524-4 | Fatty acids, reaction products with maleic anhydride and triethanolamine |
11525-5 | Fatty acids, maleated |
11554-7 | Fatty acids, reaction products with maleic anhydride and oleylamine, ethoxylated |
11560-4 | Diethylene glycol bis(phenyl mercury alkenyl)succinate |
11561-5 | Diethylene glycol bis(phenyl mercury alkenyl)succinate |
11562-6 | Diethylene glycol bis(phenyl mercury alkenyl)succinate |
11013-6 | Polymeric monobutyltin(alkylmercaptoacetate ester), substituted |
11060-8 | 2-Propanol, titanium (4+) salt, polymer with triethoxyvinylsilane; |
Note 4 The confidential accession numbers are used to identify substances listed on the confidential portion of the Domestic Substances List (DSL).
[9-1-o]
DEPARTMENT OF INDIAN AFFAIRS AND NORTHERN DEVELOPMENT
AN ACT TO AMEND THE CREE-NASKAPI (OF QUEBEC) ACT
Land set aside as Category IA land for the exclusive use and benefit of the Crees of Oujé-Bougoumou
Under section 32 of An Act to amend the Cree-Naskapi (of Quebec) Act, the Minister of Indian Affairs and Northern Development advises that the land has been set aside by the Governor in Council on May 15, 2014, as Category IA land, for the exclusive use and benefit of the community known as the Crees of Oujé-Bougoumou.
Ottawa, May 15, 2014
BERNARD VALCOURT
Minister of Indian Affairs
and Northern Development
[9-1-o]
DEPARTMENT OF INDUSTRY
BOARDS OF TRADE ACT
Chambre de Commerce de Saint-François
Notice is hereby given that His Excellency the Governor General in Council, by Order in Council dated February 5, 2015, has been pleased to change the name of the Chambre de Commerce de Saint-François to the Chambre de Commerce Haut-Madawaska/Chamber of Commerce and to change its boundaries to the regions of the Haut-Madawaska, namely Saint-François, Clair, Lac Baker, Baker-Brook and Saint-Hilaire, upon petition made therefor under sections 4 and 39 of the Boards of Trade Act.
February 11, 2015
VIRGINIE ETHIER
Director
For the Minister of Industry
[9-1-o]
DEPARTMENT OF INDUSTRY
BOARDS OF TRADE ACT
Harrison Hot Springs Chamber of Commerce
Notice is hereby given that His Excellency the Governor General in Council, by Order in Council dated November 20, 2014, has been pleased to change the name of Harrison Hot Springs Chamber of Commerce to the Harrison Agassiz Chamber of Commerce and to change its boundaries to the Village of Harrison Hot Springs and the District of Kent upon petition made therefor under sections 4 and 39 of the Boards of Trade Act.
February 18, 2015
VIRGINIE ETHIER
Director
For the Minister of Industry
[9-1-o]
DEPARTMENT OF INDUSTRY
CANADA CORPORATIONS ACT
Application for surrender of charter
Notice is hereby given that, pursuant to the provisions of subsection 32(2) of the Canada Corporations Act, an application for surrender of charter was received from
File No. | Name of Company | Received |
---|---|---|
447674-3 | AMITA Telemedicine Inc. | 12/01/2015 |
February 18, 2015
VIRGINIE ETHIER
Director
For the Minister of Industry
[9-1-o]
NOTICE OF VACANCY
MILITARY POLICE COMPLAINTS COMMISSION
Chairperson (full-time position)
Salary range: From $141,300 to $166,200
Location: National Capital Region
The Military Police Complaints Commission (MPCC) is a civilian adjudicative police oversight body governed under Part IV of the National Defence Act that reports to Parliament through the Minister of National Defence. The mandate of the MPCC is to monitor and investigate conduct complaints against the military police (MP) in the performance of their policing duties and to investigate interference complaints from the MP against members of the Canadian Armed Forces (CAF) and senior officials of the Department of National Defence (DND). The MPCC may call hearings into a complaint, whereas, it may exercise legislative authority to compel, subpoena and summon witnesses to appear and testify before the MPCC in a public forum.
The MPCC ensures all parties are treated with fairness and objectivity and, when examining complaints, consideration is given to the public interest in the fair and proper enforcement of the law.
As Deputy Head and Chief Executive Officer of the MPCC, the Chairperson is responsible for its efficient and effective operation and its administration. The Chairperson also supervises and directs the work and staff of the Commission.
The ideal candidate would possess a degree from a recognized university in a relevant field of study (such as law, criminology or criminal justice) or possess a related post-graduate degree or an acceptable combination of education, job-related training and/or experience. A degree in law would be considered an asset.
The ideal candidate would have management experience at the executive level in a private or public sector organization, including managing human and financial resources. Experience in the interpretation and application of legislation, regulations and directives is desired. The candidate would also have experience in the development and/or implementation of policy, performance standards and operational procedures. Experience in policing or law enforcement, as well as in the operation and conduct of an adjudicate tribunal, would be considered an asset.
The ideal candidate would have knowledge of the mandate, complaints process and organizational structure of the MPCC, as well as of the National Defence Act and the Canadian Charter of Rights and Freedoms and other relevant legislation. Knowledge of the operations of the federal government, including those related to sound management principles, strategic reporting, accountability and transparency, is sought. He or she would have knowledge of criminal law, administrative law, the principles of natural justice and the rules and practices followed by adjudicative tribunals in Canada. Knowledge of police administration, policing practices and professional standards of conduct would be considered an asset. Knowledge of the CAF, the MP and DND, including their respective mandates and organizational structures, would also be considered an asset.
The ideal candidate would have the ability to provide corporate vision, leadership and strategic direction needed for the Commission to attain its mandate and objectives. He or she would have sound management skills in order to motivate staff and to ensure the Commission adheres to the highest standards of accountability and transparency. Moreover, the Chairperson would have the ability to develop effective working relationships with the Minister, government officials, stakeholders and clients, while maintaining the degree of independence required of an adjudicative body. The ability to conduct fair and efficient adjudicative hearings is desired. This candidate would have the ability to interpret relevant statutes, regulations and policies, and analyze complex situations in order to make equitable and timely decisions and recommendations while also anticipating their short- and long-term consequences. Superior communication skills, both written and oral, are sought.
Along with excellent leadership and superior interpersonal skills, the ideal candidate would possess sound judgement, high ethical standards and integrity, and would be impartial, tactful and diplomatic.
Proficiency in both official languages would be preferred.
The successful candidate must reside in or be willing to relocate to the National Capital Region. He or she must be willing to travel throughout Canada and abroad as required.
An officer, a non-commissioned member of the CAF or an employee of DND is not eligible to be Chairperson of the MPCC.
The Government is committed to ensuring that its appointments are representative of Canada's regions and official languages, as well as of women, Aboriginal peoples, disabled persons and visible minorities.
The selected candidate must comply with the Ethical and Political Activity Guidelines for Public Office Holders. The Guidelines are available on the Governor in Council Appointments Web site, under “Reference Material,” at www.appointments-nominations.gc.ca/index.asp?lang=eng.
The selected candidate will be subject to the Conflict of Interest Act. Public office holders appointed on a full-time basis must submit to the Office of the Conflict of Interest and Ethics Commissioner, within 60 days of appointment, a confidential report in which they disclose all of their assets, liabilities and outside activities. For more information, please visit the Office of the Conflict of Interest and Ethics Commissioner's Web site at http://ciec-ccie.gc.ca/Default.aspx?pid=1&lang=en.
This notice has been placed in the Canada Gazette to assist the Governor in Council in identifying qualified candidates for this position. It is not, however, intended to be the sole means of recruitment.
Further details about the MPCC and its activities can be found on its Web site at http://www.mpcc-cppm.gc.ca/index-eng.aspx.
Interested candidates should forward their curriculum vitae by March 16, 2015, to the Assistant Secretary to the Cabinet (Senior Personnel), Privy Council Office, 59 Sparks Street, 1st Floor, Ottawa, Ontario K1A 0A3, 613-957-5006 (fax), GICA-NGEC@pco-bcp.gc.ca (email).
English and French notices of vacancies will be produced in an alternative format upon request. For further information, please contact GICA-NGEC@pco-bcp.gc.ca.
[9-1-o]
OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS
INSURANCE COMPANIES ACT
Esurance Insurance Company of Canada — Letters patent of incorporation and order to commence and carry on business
Notice is hereby given of the issuance,
- pursuant to section 22 of the Insurance Companies Act, of letters patent incorporating Esurance Insurance Company of Canada and, in French, Esurance du Canada, Compagnie d'Assurance, effective December 3, 2014; and
- pursuant to subsection 53(1) of the Insurance Companies Act, of an order authorizing Esurance Insurance Company of Canada, and, in French, Esurance du Canada, Compagnie d'Assurance, to commence and carry on business, effective January 23, 2015.
January 6, 2015
JEREMY RUDIN
Superintendent of Financial Institutions
[9-1-o]
BANK OF CANADA
Statement of financial position as at January 31, 2015
ASSETS | Amount | Total |
---|---|---|
Cash and foreign deposits | 5.9 | |
Loans and receivables | ||
Securities purchased under resale agreements | — | |
Advances to members of the Canadian Payments Association | — | |
Advances to governments | — | |
Other receivables | 5.3 | |
5.3 | ||
Investments | ||
Treasury bills of Canada | 20,960.1 | |
Government of Canada bonds | 72,933.1 | |
Other investments | 380.9 | |
94,274.1 | ||
Property and equipment | 288.7 | |
Intangible assets | 43.1 | |
Other assets | 186.8 | |
Total assets | 94,803.9 |
LIABILITIES AND EQUITY | Amount | Total |
---|---|---|
Bank notes in circulation | 67,339.0 | |
Deposits | ||
Government of Canada | 24,723.7 | |
Members of the Canadian Payments Association | 150.5 | |
Other deposits | 1,547.4 | |
26,421.6 | ||
Liabilities in foreign currencies | ||
Government of Canada | — | |
Other | — | |
— | ||
Other liabilities | ||
Securities sold under repurchase agreements | — | |
Other liabilities | 544.1 | |
544.1 | ||
94,304.7 | ||
Equity | ||
Share capital | 5.0 | |
Statutory and special reserves | 125.0 | |
Available-for-sale reserve | 369.2 | |
Actuarial gains reserve | — | |
Retained earnings | — | |
499.2 | ||
Total Liabilities and Equity | 94,803.9 |
I declare that the foregoing return is correct according to the books of the Bank.
Ottawa, February 13, 2015
CARMEN VIERULA
Chief Financial Officer and Chief Accountant
I declare that the foregoing return is to the best of my knowledge and belief correct, and shows truly and clearly the financial position of the Bank, as required by section 29 of the Bank of Canada Act.
Ottawa, February 13, 2015
STEPHEN S. POLOZ
Governor
[9-1-o]